TSS:Hg 84850.1

Basic information about the TSS

---

TSS ID: hg_84850.1 Species: human Chr: chr7		Start: 92836739 End: 92836746 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: NM_001145306 Distance: 113 GeneID: 1021 HGNC/MGI_ID: HGNC:1777 UniProt_ID: Q00534

Gene_name: cyclin-dependent kinase 6 Gene_symbol: CDK6 Gene_synonyms: PLSTIRE Gene_source: HGNC:1777

TATA-Box annotation

---

Distance to TSS:	-116
Nearest PromoterID:	NM_001145306
Entrez ID:	1021
Nearest Unigene:	Hs.119882
Nearest Refseq:	NM_001259
Nearest Ensembl:	ENSG00000105810
Gene Name:	cyclin-dependent kinase 6
Gene Alias:	MCPH12
Gene Description:	cyclin dependent kinase 6
Gene Type:	protein-coding
CpG%:	0.12
GC%:	0.791045
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CDK6 p2@CDK6 p3@CDK6 p4@CDK6 p5@CDK6 p6@CDK6 p7@CDK6 p8@CDK6 p9@CDK6 p10@CDK6
Sample		p1@CDK6	p2@CDK6	p3@CDK6	p4@CDK6	p5@CDK6	p6@CDK6	p7@CDK6	p8@CDK6	p9@CDK6	p10@CDK6
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	20.06	1.95	0.00	0.39	0.39	0.58	0.00	0.19	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	21.24	1.42	0.61	0.61	0.40	0.81	0.40	0.40	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	22.57	3.09	0.19	1.16	0.77	1.16	0.39	0.19	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	19.34	2.29	0.00	0.42	0.42	1.25	0.42	0.42	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	23.40	1.35	0.00	0.45	0.22	0.90	0.00	0.00	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	23.26	2.52	1.16	0.97	1.16	1.94	0.58	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	23.75	2.61	0.44	0.65	1.31	1.96	0.65	0.22	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	20.10	2.18	0.24	1.94	0.73	0.97	0.24	0.24	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	20.52	1.71	0.00	0.64	1.28	2.35	0.85	0.85	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	15.65	1.16	0.00	1.74	0.00	1.16	1.16	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	15.36	0.00	0.40	1.62	0.00	4.45	0.81	0.40	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	18.29	1.63	0.00	0.81	0.41	1.22	0.41	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	25.95	3.71	0.97	0.64	0.32	1.29	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	22.40	4.81	1.35	0.60	1.20	1.20	0.90	0.00	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	16.69	3.07	0.44	0.44	1.98	0.88	1.54	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	17.10	3.52	1.26	0.00	0.25	0.50	0.25	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	22.50	3.71	0.66	0.44	0.66	0.22	0.87	0.22	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	21.09	3.80	0.42	0.84	0.84	0.42	0.42	0.42	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	23.99	2.13	0.53	0.00	2.67	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	19.86	3.91	0.60	0.15	0.45	0.30	1.05	0.60	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	24.46	4.95	0.53	0.80	0.53	0.27	1.20	0.13	0.13	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	19.85	3.80	0.35	0.35	0.52	0.52	0.86	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	21.59	3.10	0.52	0.52	0.39	0.52	0.65	0.26	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	21.84	3.64	0.73	0.00	0.49	0.24	0.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	16.00	3.61	0.26	0.00	1.55	0.26	2.06	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	16.14	2.85	0.32	0.32	0.95	1.90	0.63	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	23.63	4.40	0.55	0.55	0.55	0.55	2.20	0.00	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	28.05	5.42	0.71	0.24	0.47	0.94	2.83	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	21.32	2.91	0.65	1.13	0.48	0.81	0.81	0.00	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	21.72	4.16	0.90	1.09	0.90	0.54	1.45	0.00	0.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	19.47	3.35	0.42	0.42	1.05	1.05	0.84	0.21	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	21.69	4.88	0.20	1.37	0.59	0.59	2.34	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	20.68	4.22	0.84	0.63	0.84	0.63	1.27	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	23.92	4.95	1.15	1.32	0.82	0.82	1.65	0.82	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	20.76	4.11	0.19	0.37	1.68	0.93	1.50	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	21.46	5.75	2.11	0.19	0.77	1.34	1.15	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	26.16	6.95	2.04	0.61	1.43	1.02	1.64	0.20	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	18.74	5.04	1.01	1.21	1.01	0.00	2.22	0.60	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	17.83	3.24	1.35	0.54	0.81	0.00	1.35	0.27	0.54	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	17.76	6.48	0.72	0.72	0.96	0.24	2.16	0.48	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	18.35	5.41	1.18	0.94	1.65	0.24	1.65	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	23.57	6.44	0.73	1.17	0.59	0.44	0.88	0.15	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	21.09	5.69	0.42	0.63	0.84	0.63	1.69	0.00	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	25.87	5.59	0.52	1.22	0.35	0.52	2.80	0.52	0.70	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	18.27	3.21	1.20	0.80	0.60	0.60	3.21	0.20	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	21.17	4.89	1.40	0.93	0.00	0.23	0.70	0.00	0.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	23.27	3.84	0.96	1.20	0.24	0.96	2.40	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	17.58	5.07	1.49	0.60	0.89	0.30	0.89	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	23.94	6.46	0.96	0.72	1.20	0.72	1.68	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	21.03	4.45	2.43	1.42	1.42	0.81	2.02	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	31.15	7.17	1.02	1.64	1.43	0.41	2.25	0.00	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	32.69	5.78	2.89	2.00	1.56	0.89	2.22	0.00	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	41.98	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	21.29	3.90	0.71	1.06	0.35	1.06	2.84	0.00	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	30.82	6.63	0.33	1.33	1.66	1.66	1.99	0.00	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	42.79	8.39	5.03	2.52	0.00	0.00	1.68	1.68	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	30.77	8.73	0.46	0.92	0.92	0.92	1.84	0.46	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	27.23	4.86	0.65	1.30	0.32	1.30	0.97	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	23.77	3.21	0.64	0.96	1.28	0.64	0.96	0.00	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	31.43	11.94	1.89	1.89	0.63	0.94	0.94	0.63	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.73	6.35	0.00	2.82	0.71	0.00	2.12	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	40.94	3.93	0.00	0.56	2.24	1.12	2.80	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	36.62	14.33	5.57	0.80	0.80	0.80	4.78	0.80	6.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	38.39	10.87	3.40	2.38	0.68	1.36	1.36	0.34	0.34	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	39.64	10.40	1.30	1.62	1.30	1.95	3.25	0.00	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	37.98	5.32	1.42	1.42	0.71	0.35	2.48	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	161.64	48.49	16.16	0.00	0.00	0.00	0.00	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	142.15	47.38	0.00	0.00	0.00	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	60.45	12.19	0.98	0.00	2.44	3.41	2.44	0.00	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	50.58	13.39	1.49	0.99	2.48	1.98	0.00	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	58.64	12.20	1.41	1.41	0.94	1.88	1.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	47.69	13.58	1.32	0.66	0.66	0.66	3.31	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	52.59	9.59	1.24	0.00	0.93	1.86	1.55	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	46.78	7.64	1.22	0.61	0.92	0.92	1.22	0.00	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	6.81	4.12	0.16	1.74	0.95	0.00	0.16	0.00	0.48	0.16
Adipocyte - breast, donor2	11327-117E4	5.78	2.41	0.48	1.44	0.16	0.16	0.32	0.16	0.32	0.32
Adipocyte - omental, donor1	11473-119C6	4.45	3.94	0.76	1.65	1.02	0.00	0.00	0.13	0.00	0.64
Adipocyte - omental, donor2	11474-119C7	7.47	1.49	0.00	0.75	0.00	0.75	0.00	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	2.68	2.01	0.67	0.67	0.00	0.00	0.00	0.00	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	8.29	2.55	0.00	1.28	0.64	0.00	0.64	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	9.03	0.90	0.45	0.90	0.00	0.45	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	1.56	1.04	0.17	0.52	0.52	0.00	0.00	0.00	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	1.96	1.76	0.00	0.39	0.39	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	2.57	1.54	0.00	0.77	0.51	0.00	0.00	0.00	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	2.79	2.79	0.56	0.84	0.56	0.00	0.00	0.00	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	1.76	1.18	0.59	0.00	0.59	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	2.98	1.13	0.40	0.97	0.32	0.00	0.00	0.16	0.16	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	1.61	0.97	0.32	0.32	0.00	0.00	0.00	0.00	0.00	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	2.13	0.00	0.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	0.00	1.11	0.00	1.11	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	1.66	0.83	0.00	0.00	0.83	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	1.00	0.50	0.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	3.27	1.64	0.65	1.64	0.33	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	1.83	0.61	0.91	0.30	0.30	0.00	0.00	0.00	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	20.11	2.65	0.22	0.00	0.44	0.66	0.22	0.00	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	8.25	1.43	0.36	0.36	0.36	0.36	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	58.83	3.60	0.72	0.90	0.90	1.80	0.54	0.36	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	0.00	0.00	0.00	5.02	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	30.61	2.26	0.21	0.21	0.82	0.82	0.00	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	5.49	2.98	0.34	0.69	0.23	0.00	0.00	0.23	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	6.61	1.47	0.49	0.00	0.49	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	15.28	5.39	2.70	0.45	0.00	0.90	0.00	0.00	1.80	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	13.02	5.64	1.74	0.43	2.17	0.00	0.43	0.00	1.74	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	10.70	0.00	0.00	4.28	2.14	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	16.14	4.18	1.20	0.90	0.60	0.00	0.00	0.60	0.90	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	7.59	1.26	1.26	0.00	0.00	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	12.54	3.96	0.66	4.62	0.66	0.66	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.32	5.20	0.97	1.30	0.65	0.65	0.00	0.32	0.97	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	15.05	5.83	0.49	0.97	0.00	0.49	0.49	0.00	1.94	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.07	2.38	0.59	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	13.56	5.65	1.88	1.13	1.13	0.75	1.13	0.38	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	11.61	6.53	0.73	0.73	1.45	0.73	0.00	0.00	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	1.25	1.25	0.00	0.00	0.00	0.00	1.25	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	17.46	4.61	0.99	0.66	0.99	0.49	0.00	0.33	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	16.38	1.36	0.00	1.36	0.00	1.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	14.33	2.71	1.51	0.30	0.30	0.60	0.00	0.30	0.90	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	13.39	3.75	0.54	1.07	0.00	1.07	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	15.87	4.35	0.94	0.19	0.38	0.76	0.00	0.57	0.76	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	16.57	5.61	0.80	1.07	0.27	0.00	0.00	0.27	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	14.63	5.85	0.00	0.00	0.98	0.00	0.00	0.00	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	12.11	3.48	0.33	0.83	0.17	0.66	0.00	0.17	1.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	6.00	0.00	0.00	0.00	0.00	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	7.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	14.24	4.97	0.69	1.37	0.51	0.51	0.17	0.34	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	10.68	3.40	1.46	0.97	0.00	0.00	0.49	0.00	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	13.28	6.07	1.14	0.76	0.00	0.76	0.76	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	10.90	3.63	0.00	0.00	0.00	1.21	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	12.54	6.84	0.00	0.57	1.14	0.57	0.00	0.00	1.71	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	10.69	3.63	0.43	0.43	0.21	0.00	0.21	0.21	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	13.42	4.65	1.03	0.52	0.52	0.26	0.00	0.00	0.26	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	11.26	1.88	0.94	0.47	0.47	0.47	0.47	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	14.15	4.82	0.96	0.96	0.64	0.32	0.32	0.96	0.64	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	13.56	4.28	1.43	1.43	0.00	0.00	0.00	0.00	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	14.62	1.17	1.75	1.17	0.00	0.00	0.00	0.00	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	13.85	4.52	0.60	0.30	0.30	0.30	0.00	0.90	0.60	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	19.01	5.94	3.56	0.00	1.19	0.00	1.19	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	16.27	4.58	1.02	0.51	0.00	0.51	0.00	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	19.10	6.37	1.27	0.25	0.76	0.76	0.25	0.51	1.53	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	14.61	4.45	1.27	0.64	0.00	0.64	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	11.65	3.45	1.73	0.86	0.00	1.29	0.00	0.43	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.66	6.56	1.27	0.42	0.21	0.42	0.00	0.21	0.85	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.31	2.32	0.00	1.45	0.58	0.58	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	15.12	3.78	0.94	0.00	0.94	0.94	0.00	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.39	5.93	1.53	0.17	0.85	1.19	0.34	0.17	0.68	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	2.32	0.00	0.00	0.00	0.00	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	19.01	4.23	0.00	2.11	0.00	0.00	0.00	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.65	6.65	0.86	0.86	0.21	0.00	0.00	0.21	1.29	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	11.43	0.60	1.20	0.60	0.00	0.00	0.00	0.00	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	16.77	3.64	2.19	0.00	0.00	0.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	17.70	6.44	1.15	0.69	0.69	1.15	0.46	0.00	1.38	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	5.10	5.10	0.00	0.00	2.55	0.00	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	20.59	3.81	1.53	0.51	0.00	0.51	0.25	0.25	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	19.20	7.64	1.03	0.83	0.21	0.83	0.41	0.00	1.45	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	15.30	7.34	0.92	0.92	0.61	0.00	0.31	0.61	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	15.77	2.87	0.48	1.43	0.48	0.48	0.00	0.48	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.30	5.10	2.00	0.22	0.22	0.44	0.22	0.22	0.67	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	6.10	4.58	1.53	1.53	0.00	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	12.74	4.43	1.11	0.00	0.55	1.11	0.00	0.00	2.77	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	18.54	5.30	1.59	0.53	0.53	0.53	0.53	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	14.54	4.00	1.09	2.18	0.00	0.00	0.00	0.00	1.09	0.00
Astrocyte - cerebellum, donor1	11500-119F6	28.25	15.47	2.33	0.49	0.49	0.61	0.74	0.12	0.25	0.12
Astrocyte - cerebellum, donor2	11580-120F5	21.05	7.53	1.20	0.86	0.68	1.03	0.86	0.00	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	14.89	4.40	1.05	0.63	0.84	0.63	0.63	0.42	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	18.13	27.54	3.49	0.70	1.74	0.35	0.35	0.70	1.05	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	24.10	31.22	4.04	2.91	0.97	0.32	0.65	0.49	1.46	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	21.48	25.21	4.33	1.94	1.19	0.30	0.60	0.30	0.15	1.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	68.81	16.86	1.38	1.61	5.50	2.06	2.06	0.11	0.69	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	74.17	18.92	3.51	0.88	6.51	2.38	2.88	0.13	0.38	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	68.73	16.96	2.62	1.25	5.35	2.05	3.64	0.46	0.80	1.02
Basophils, donor1	12241-129G9	6.54	3.14	0.52	0.78	0.00	0.00	0.26	0.78	0.26	0.00
Basophils, donor2	12242-129H1	13.35	3.61	0.72	2.16	0.36	0.36	0.72	0.36	0.36	0.00
Basophils, donor3	12243-129H2	6.47	1.91	0.15	0.73	0.44	0.15	0.00	0.44	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	18.54	1.72	0.00	0.00	0.00	0.65	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	10.52	0.00	0.00	0.00	0.00	0.46	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	29.50	1.26	0.00	0.00	0.00	0.63	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	20.17	1.25	0.21	0.42	0.21	0.62	0.42	0.00	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	12.90	0.46	0.00	0.00	0.00	0.23	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	37.61	1.80	0.18	0.00	1.08	0.54	0.54	0.00	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	37.00	13.91	1.85	0.62	2.89	1.65	0.10	0.62	0.41	0.62
Burkitt's lymphoma cell line:RAJI	10476-106I8	71.04	24.45	3.96	2.79	4.89	3.96	0.00	0.23	2.79	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	205.30	90.50	15.67	4.80	2.56	7.04	6.08	7.67	3.84	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	382.65	165.47	41.37	0.00	0.00	10.34	0.00	10.34	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	6.20	7.89	0.56	1.13	1.13	0.00	0.56	1.69	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	6.68	5.20	1.48	2.04	0.37	0.00	0.56	0.93	0.19	0.19
CD14+ Monocytes, donor3	11381-118B4	7.68	4.83	1.32	1.54	1.76	0.44	0.44	1.54	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	3.68	1.98	1.42	0.85	0.57	0.00	0.28	0.00	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	9.10	6.07	0.00	0.76	1.14	0.00	0.38	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	4.60	2.63	0.33	1.31	0.99	0.33	0.33	0.33	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	0.14	1.16	0.00	0.14	0.00	0.00	0.00	0.72	0.29	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	0.30	0.91	0.60	0.00	0.00	0.00	0.00	0.30	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	1.42	1.18	0.24	0.47	0.00	0.00	0.24	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.50	1.17	0.17	0.50	0.00	0.00	0.00	0.17	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	1.93	0.28	0.28	0.00	0.00	0.00	0.00	0.28	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	1.24	0.25	0.25	0.00	0.00	0.00	0.00	0.50	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	1.37	1.76	0.59	0.78	0.20	0.00	0.00	0.59	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	1.25	3.20	0.18	0.36	0.00	0.00	0.00	1.07	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.22	3.26	0.87	1.74	0.00	0.00	0.00	0.65	0.22	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1.17	3.75	0.70	0.23	0.00	0.00	0.23	1.17	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1.58	4.22	0.00	0.53	0.53	0.00	0.00	0.00	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	6.66	2.22	1.11	1.11	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.59	0.74	0.00	0.30	0.00	0.00	0.00	0.30	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	0.40	0.80	0.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	1.46	1.25	0.62	0.42	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.69	3.43	0.46	0.69	0.00	0.00	0.00	0.46	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	1.81	2.71	0.68	0.68	0.23	0.00	0.23	1.13	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	2.62	2.62	0.44	0.87	0.00	0.00	0.44	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1.08	1.61	0.27	0.81	0.00	0.00	0.00	0.27	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1.05	1.57	0.35	1.22	0.00	0.17	0.17	1.05	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	1.26	2.10	0.00	2.10	0.00	0.00	0.00	0.84	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1.47	1.65	0.18	0.18	0.18	0.00	0.00	0.37	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1.06	1.06	0.70	0.70	0.00	0.00	0.00	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.07	0.88	0.00	0.44	0.00	0.00	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	1.22	0.87	0.00	0.87	0.35	0.00	0.00	0.70	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	1.49	1.12	0.74	1.12	0.00	0.00	0.00	0.74	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	2.80	3.66	0.43	0.22	0.00	0.00	0.00	0.86	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	1.64	0.41	0.00	0.82	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1.39	1.39	0.23	0.46	0.23	0.00	0.00	0.46	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	2.32	2.55	0.00	0.93	0.00	0.00	0.00	0.46	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	3.71	5.45	1.53	1.09	0.22	0.00	0.00	3.05	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	3.70	5.54	0.69	0.69	0.23	0.00	0.00	1.15	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	2.60	4.12	0.00	1.08	0.43	0.00	0.00	1.08	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	2.96	3.74	0.78	0.93	0.16	0.00	0.00	0.78	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	2.79	3.67	0.52	0.35	0.35	0.00	0.17	0.00	0.00	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	3.79	3.34	0.45	0.45	0.00	0.00	0.22	0.22	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	2.04	7.40	1.79	0.77	0.00	0.00	0.00	1.28	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	3.29	7.03	2.42	1.32	0.44	0.00	0.00	1.32	0.00	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	1.47	7.79	2.11	1.05	0.42	0.00	0.21	2.53	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	24.39	6.10	0.00	2.03	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	21.02	3.39	0.68	1.36	2.03	1.36	0.68	0.00	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	18.64	2.07	0.00	0.00	1.04	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	28.25	3.73	0.53	1.07	0.00	0.53	0.53	0.53	1.60	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	22.51	4.29	0.54	0.00	0.54	0.00	0.54	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	19.65	3.51	0.00	0.70	1.40	0.70	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	22.75	5.49	0.00	0.00	0.78	0.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	30.32	5.27	0.00	0.00	0.00	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	20.55	2.47	2.47	0.00	0.82	0.00	0.00	0.00	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	18.14	4.35	0.00	0.00	0.00	0.00	0.00	0.00	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	19.18	2.52	0.50	0.00	1.01	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	35.56	6.87	0.00	0.00	0.00	0.81	0.40	0.00	0.81	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	23.57	8.39	0.00	0.00	0.00	2.00	0.00	0.00	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	164.66	71.29	9.04	5.02	3.01	8.03	8.03	7.03	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	91.01	41.01	6.74	6.74	0.56	3.93	3.93	2.25	1.12	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	187.50	45.84	10.15	3.38	5.64	4.88	3.76	6.39	3.01	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	191.66	50.28	11.27	2.25	4.51	5.19	3.61	5.41	2.03	0.23
CD4+ T Cells, donor1	11225-116C1	34.99	16.78	1.79	0.71	3.57	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	22.66	13.47	2.45	1.22	0.00	0.00	0.00	0.00	2.45	0.00
CD4+ T Cells, donor3	11382-118B5	15.86	11.59	1.52	0.91	1.83	0.30	0.30	0.00	0.00	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	43.39	23.99	0.26	3.57	2.04	0.26	0.00	0.00	0.26	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	46.94	25.15	1.35	3.37	2.25	0.45	0.22	0.00	2.02	1.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	47.43	27.31	0.57	2.30	1.15	0.29	0.00	0.00	2.01	3.45
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	21.81	5.22	0.00	0.00	1.42	0.95	0.47	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	28.09	4.21	0.70	0.00	3.51	0.70	0.00	0.00	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	9.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	29.05	23.99	2.46	4.77	2.02	0.72	0.29	0.00	0.29	2.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	16.95	23.56	2.20	2.88	1.36	0.34	0.00	0.17	0.34	1.36
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	20.80	29.82	0.81	5.16	1.29	0.81	0.16	0.00	0.81	2.26
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	7.62	8.52	0.00	0.90	0.90	0.00	0.45	0.00	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	8.39	5.94	1.05	0.70	0.35	0.00	0.00	0.35	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	10.12	10.56	0.44	1.32	0.88	0.44	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	82.22	69.57	6.75	5.90	1.69	1.69	0.00	0.00	0.42	2.53
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	48.83	45.92	4.78	4.78	0.42	1.87	0.21	0.42	2.29	2.70
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	43.77	50.12	6.68	2.00	1.67	0.00	1.00	1.34	2.67	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	62.82	27.74	2.18	0.82	1.09	0.82	1.36	0.00	1.09	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	75.03	22.51	3.22	0.00	3.75	0.00	0.54	0.00	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	30.48	8.97	0.00	1.79	1.79	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	64.90	38.20	1.67	5.75	1.85	1.67	0.56	0.19	0.56	2.41
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	39.42	30.33	3.68	3.47	1.95	0.65	0.22	0.00	1.08	1.52
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	50.02	31.94	2.94	6.09	1.26	0.63	0.84	0.21	0.21	2.10
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	27.30	14.16	1.52	3.54	1.01	1.52	1.01	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	20.80	10.83	0.43	0.00	0.87	0.87	0.43	0.43	0.00	2.60
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	27.89	8.72	0.87	1.74	0.44	0.44	0.44	0.44	0.87	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	44.04	16.33	0.99	1.48	2.47	0.99	1.98	0.00	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	35.08	14.77	0.00	1.85	0.92	0.92	0.92	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	46.06	5.58	1.40	0.00	0.00	1.40	0.00	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	38.77	8.58	0.28	0.28	0.83	0.28	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	49.32	11.53	1.23	0.74	0.98	1.47	0.49	0.25	0.00	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	64.68	12.32	1.54	1.54	3.08	4.62	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	49.78	14.32	1.79	1.07	3.58	0.36	1.43	0.36	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	49.86	8.31	0.00	1.38	2.77	0.00	0.00	1.38	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	37.98	8.84	0.33	1.96	1.64	0.65	0.98	0.00	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	21.02	4.51	0.00	0.75	0.75	0.75	0.00	0.38	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	26.26	7.32	1.26	1.77	0.25	0.25	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	43.13	13.76	3.21	1.61	0.69	0.69	11.70	0.00	0.46	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	43.14	10.30	3.59	0.48	1.20	0.72	7.91	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	40.49	12.04	3.83	1.09	3.01	1.09	5.20	0.27	0.00	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	38.13	18.31	2.70	2.10	0.90	1.50	15.31	0.60	0.30	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	50.88	15.84	3.12	0.24	1.44	1.68	12.00	0.00	0.24	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	43.66	13.19	3.18	1.36	2.27	2.27	11.60	0.68	0.68	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	48.67	13.25	3.26	0.65	1.09	1.74	12.17	0.43	0.65	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	41.59	11.84	3.16	0.26	2.37	1.84	13.69	0.26	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	49.48	12.90	3.05	0.47	2.58	2.11	10.55	0.00	0.47	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	35.92	14.49	2.72	1.51	2.42	1.21	11.47	0.30	0.30	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	43.29	13.94	2.03	1.16	2.03	1.74	6.97	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	42.63	12.79	2.93	0.53	3.20	0.53	13.59	0.00	0.00	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	34.14	10.07	1.75	1.31	0.88	2.63	25.83	0.00	0.88	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	41.44	16.85	3.64	1.82	3.64	4.10	29.60	0.91	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	29.09	7.46	2.98	0.00	2.24	2.98	22.38	0.00	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	47.54	15.13	5.04	1.08	1.08	2.52	16.93	0.00	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	47.76	16.69	3.45	1.15	3.45	2.59	10.07	0.29	0.29	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	39.36	14.38	2.83	0.47	2.12	2.36	14.61	1.18	0.71	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	62.43	16.16	5.07	0.95	0.95	3.17	17.43	0.95	0.32	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	57.51	16.61	5.54	0.62	2.46	3.08	20.61	0.92	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	51.29	10.26	5.13	1.28	2.89	2.89	13.79	0.96	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	52.78	17.59	2.68	1.91	3.82	1.53	19.51	0.38	0.38	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	51.63	11.03	2.76	1.18	2.36	1.97	12.22	0.39	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	52.19	21.94	2.27	1.51	1.51	3.03	12.86	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	73.07	22.48	2.41	0.80	4.01	4.01	18.47	0.80	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	64.35	18.19	2.10	2.10	3.50	2.10	20.98	0.70	2.10	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	70.12	18.03	4.01	0.00	3.01	3.01	16.03	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	5.48	5.48	1.83	5.48	0.00	0.00	0.00	1.83	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	12.35	4.45	1.98	1.48	0.00	0.49	0.49	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	13.47	3.37	0.63	0.63	0.63	0.42	0.32	0.21	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	10.75	6.59	0.69	1.73	1.04	0.00	0.00	0.69	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	6.75	2.13	0.36	2.84	0.36	0.00	0.00	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	5.01	3.53	0.68	1.25	0.91	0.11	0.23	0.23	0.00	0.23
Chondrocyte - re diff, donor2	11339-117F7	8.95	3.58	0.90	0.90	1.79	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	8.90	4.04	0.00	0.81	0.81	0.40	0.00	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	52.56	23.75	3.79	3.67	3.10	1.95	1.26	1.15	0.69	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	41.47	11.12	2.78	1.50	2.35	1.28	0.64	0.21	1.28	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	35.75	10.80	2.65	1.42	1.42	0.80	0.88	0.44	0.53	0.71
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	7.89	9.90	0.55	1.56	1.01	0.37	0.46	0.09	0.00	0.55
Corneal Epithelial Cells, donor1	11526-119I5	11.64	0.22	0.00	0.00	0.22	0.22	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	13.65	0.00	0.00	0.00	0.00	2.28	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	16.87	0.51	0.00	0.26	0.26	0.77	0.26	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	3.47	7.59	0.66	0.33	0.33	0.00	0.17	0.66	0.66	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	5.99	6.31	0.63	0.95	0.63	0.00	0.32	1.26	0.00	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	3.45	3.45	0.00	0.00	0.00	0.00	6.90	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	3.13	6.48	1.19	1.08	0.76	0.00	0.11	1.19	0.22	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	55.35	3.76	0.00	1.02	2.73	0.68	2.39	0.68	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	40.48	6.53	1.31	1.96	1.31	0.00	1.31	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	52.75	6.29	0.00	2.42	2.90	0.48	0.00	1.45	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	4.17	1.00	0.00	0.17	0.33	0.17	0.00	0.33	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	4.11	0.00	0.00	0.00	0.00	0.00	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	3.39	0.00	0.28	0.28	0.00	0.28	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	7.08	0.79	0.00	0.00	0.39	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	4.36	1.45	0.29	0.29	0.00	0.00	0.29	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	8.47	2.59	0.00	0.24	0.00	0.47	0.47	0.00	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	7.89	1.75	0.00	0.88	0.18	0.18	0.18	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	21.72	0.44	0.00	0.22	1.11	0.22	0.22	0.00	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	24.34	2.13	0.91	0.30	0.30	0.00	0.30	0.00	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	36.65	1.69	0.00	0.00	1.13	1.41	0.56	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	7.73	2.67	0.30	0.30	0.59	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	16.66	0.52	0.00	0.00	0.52	0.00	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	9.78	0.71	0.00	0.00	0.14	0.28	0.00	0.00	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	20.41	0.80	0.00	0.00	1.20	1.60	0.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	12.58	2.10	0.00	0.00	0.00	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	16.52	4.47	0.50	0.87	1.37	0.25	0.12	0.12	0.00	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	6.95	3.48	0.65	0.87	0.65	0.00	0.00	0.22	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	12.58	3.66	0.37	0.85	0.61	0.61	0.24	0.12	0.12	0.00
Endothelial Cells - Vein, donor1	11267-116G7	5.69	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	9.08	0.70	0.00	0.00	0.00	0.70	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	7.69	0.47	0.00	0.16	0.31	0.00	0.47	0.00	0.00	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	0.00	0.00	3.30	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	3.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	12.46	0.98	0.00	0.73	0.24	0.00	0.00	0.00	0.00	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	16.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.55	1.64	0.41	0.82	0.41	0.00	0.00	0.41	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.26	1.53	0.22	0.33	0.44	0.22	0.11	0.11	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	3.36	2.49	0.65	1.08	0.00	0.00	0.11	0.00	0.00	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	11.40	7.52	0.61	2.06	0.36	0.12	0.12	0.12	0.24	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	51.04	7.51	1.23	1.64	2.32	1.36	0.27	0.41	0.27	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	8.12	3.59	0.42	1.27	1.05	0.00	0.21	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.28	6.59	0.53	2.37	0.53	0.26	0.00	0.00	0.00	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	9.30	4.98	0.66	0.33	0.66	0.33	0.00	0.33	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	16.33	1.81	1.36	1.36	0.45	2.27	0.45	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	23.50	2.27	0.00	2.27	0.00	0.76	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	14.35	3.31	0.32	0.16	0.32	0.47	0.32	0.00	0.32	0.00
Fibroblast - Cardiac, donor4	11452-119A3	18.49	4.85	1.21	1.52	0.91	0.00	0.61	0.30	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	12.94	4.19	0.76	0.76	0.63	0.51	0.25	0.38	0.38	0.25
Fibroblast - Cardiac, donor6	11460-119B2	12.43	4.09	0.30	0.76	1.67	0.30	0.00	0.00	0.76	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	13.27	5.23	1.34	1.34	0.67	0.27	0.27	0.13	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.20	5.61	1.73	0.86	1.29	0.00	0.00	0.43	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	29.30	14.65	0.00	2.93	0.00	0.00	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	12.22	4.38	0.69	1.61	0.46	0.00	0.23	0.46	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	10.52	3.56	1.87	0.51	1.36	0.00	0.17	0.17	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	6.10	0.00	0.23	0.00	0.70	0.00	0.23	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	7.08	1.89	0.47	0.00	0.47	0.94	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	12.21	1.21	0.24	0.00	0.36	0.48	0.12	0.48	0.24	0.00
Fibroblast - Dermal, donor4	11450-119A1	28.71	7.57	1.02	0.68	1.36	0.68	0.68	0.57	0.11	0.34
Fibroblast - Dermal, donor5	11454-119A5	31.92	9.42	1.57	0.52	2.09	1.40	0.52	0.35	0.87	0.00
Fibroblast - Dermal, donor6	11458-119A9	29.56	5.68	1.30	0.97	1.14	0.65	0.16	0.00	0.65	0.97
Fibroblast - Gingival, donor1	11237-116D4	23.53	4.37	0.62	2.71	1.67	0.21	0.21	0.21	0.42	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	62.36	14.41	3.14	1.83	1.57	1.57	0.52	0.79	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	27.28	6.46	0.92	0.92	1.05	0.53	0.40	0.00	0.26	0.00
Fibroblast - Gingival, donor3	11394-118C8	7.44	3.87	0.39	1.64	0.87	0.10	0.10	0.19	0.19	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	28.05	7.27	0.00	2.08	1.04	1.04	1.04	1.04	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	26.25	7.93	1.94	1.59	0.53	0.53	0.53	0.18	0.35	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	23.70	13.87	1.40	4.83	0.62	0.47	0.00	0.16	0.31	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	32.59	7.44	0.95	2.03	0.68	0.68	0.41	0.27	0.27	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	59.99	17.29	2.82	3.18	1.41	0.35	1.06	0.35	0.00	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	29.40	10.24	1.46	2.92	1.61	0.73	0.00	0.29	0.58	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	27.54	14.73	2.05	4.64	0.68	0.68	0.00	0.68	1.23	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	58.36	14.48	2.52	2.30	0.88	1.97	1.43	0.66	0.77	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	35.36	7.04	2.05	1.03	2.05	0.88	0.29	0.44	0.44	0.15
Fibroblast - Lung, donor1	11270-116H1	4.08	1.36	0.00	1.36	1.36	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	14.92	2.98	0.00	1.49	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	6.75	0.63	0.21	0.21	0.84	0.21	0.21	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	5.00	0.83	0.83	0.00	0.83	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	0.00	0.00	1.40	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.52	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	16.64	4.47	0.81	0.81	0.41	0.00	0.00	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	25.99	7.37	0.78	1.16	1.55	0.58	0.00	0.00	0.58	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	33.22	9.40	1.52	1.37	2.28	1.06	0.15	0.00	0.30	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	53.55	7.04	0.92	2.14	1.53	2.14	0.61	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	21.75	8.40	1.91	1.91	0.76	0.76	0.00	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	19.71	4.86	1.08	2.16	0.27	0.54	0.00	0.00	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	16.00	5.91	1.86	1.39	0.46	0.23	0.70	0.35	0.35	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	20.45	4.42	0.99	1.33	0.88	0.33	0.11	0.22	0.33	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	3.66	1.22	0.20	0.81	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	7.35	2.00	0.00	0.00	0.67	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	4.74	1.98	0.79	0.40	1.19	0.00	0.40	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	47.23	14.69	2.18	3.97	1.98	1.39	1.19	0.79	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	22.74	4.62	0.18	1.60	1.42	1.24	0.00	0.18	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	16.16	4.14	0.79	0.20	0.79	0.00	0.20	0.20	0.20	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	27.08	12.94	0.60	3.91	0.60	0.30	0.60	0.60	0.00	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	19.22	6.37	1.73	1.08	0.54	0.32	0.00	0.00	0.43	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	20.75	10.12	1.27	1.77	2.02	0.51	1.27	0.51	0.25	0.76
Fibroblast - skin normal, donor1	11553-120C5	12.63	4.76	0.33	1.31	0.82	0.33	0.00	0.49	0.16	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	39.30	16.04	1.80	2.61	2.21	0.00	0.60	1.20	0.40	0.40
Fibroblast - skin normal, donor2	11561-120D4	10.55	5.83	0.90	1.00	0.60	0.20	0.00	0.40	0.00	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	32.94	12.09	1.81	2.12	1.51	0.91	0.30	0.60	0.30	2.12
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	21.29	3.89	0.50	1.08	1.49	0.08	0.33	0.41	0.08	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	10.60	3.76	0.51	1.71	1.03	0.17	0.17	0.34	0.17	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	34.16	6.57	1.31	2.96	0.33	0.66	0.33	0.33	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	25.46	5.86	1.70	1.28	1.28	0.96	0.21	0.43	0.85	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	15.86	5.23	0.67	0.84	0.51	0.34	0.17	0.34	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	12.23	3.29	0.16	0.63	0.47	0.31	0.00	0.16	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	44.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	16.56	2.61	0.00	0.87	1.74	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	59.81	2.08	0.00	0.00	1.91	1.39	0.17	0.17	0.52	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	86.14	4.68	0.52	0.78	2.08	2.08	0.52	0.00	0.52	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	81.76	3.07	0.51	0.00	1.79	4.09	0.26	0.00	1.02	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	4.59	5.36	0.00	0.00	0.00	0.00	0.00	0.77	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	6.38	4.47	1.91	1.91	0.00	2.55	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	3.71	6.56	0.57	0.57	0.57	0.29	0.57	0.29	0.57	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	3.86	4.14	0.28	0.00	0.55	0.28	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	6.16	5.94	0.68	0.91	0.91	0.46	0.46	0.00	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	5.94	5.35	0.00	1.39	0.40	0.59	0.99	0.20	0.00	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	3.70	2.91	0.53	0.00	0.79	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	8.15	4.89	0.33	0.65	0.65	0.98	1.96	0.00	0.98	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	3.10	6.63	0.88	0.88	0.00	0.44	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	10.32	8.90	0.85	0.42	1.84	0.57	0.28	0.00	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	7.88	8.99	0.74	0.62	0.49	0.25	0.12	0.49	0.49	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	7.25	8.60	0.81	0.81	0.27	0.81	0.00	0.27	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	18.34	9.91	1.73	0.62	1.36	0.25	0.87	0.00	0.50	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	15.23	13.57	1.38	0.69	1.25	0.97	0.55	0.55	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	11.99	8.74	1.63	0.41	0.61	0.61	0.81	0.41	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	15.52	4.79	1.14	0.68	0.91	0.68	1.14	0.91	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	12.71	7.35	0.87	0.75	0.62	0.87	0.75	0.25	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	11.58	11.58	0.44	0.87	0.87	0.44	0.87	0.44	0.44	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	13.89	5.32	0.89	0.00	1.48	0.59	0.89	0.30	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	16.53	8.27	2.07	0.64	2.38	0.79	1.11	1.43	0.64	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	18.99	10.28	1.12	1.12	1.56	0.67	0.89	0.45	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	23.19	8.07	2.02	0.40	0.60	1.61	1.01	0.00	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	17.13	6.45	2.71	0.51	1.19	0.68	1.53	0.68	0.17	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	28.38	11.00	2.39	1.24	0.89	1.06	1.51	0.80	0.35	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.55	10.41	1.77	0.62	2.81	0.31	1.56	0.52	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	25.10	10.59	1.37	0.51	2.22	0.17	1.54	1.02	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	16.49	10.73	1.88	0.33	1.66	0.77	1.22	0.66	0.11	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	24.71	12.15	1.75	1.25	1.41	0.50	1.83	1.16	0.75	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	21.85	8.37	1.84	0.61	1.23	0.82	1.02	0.41	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	18.57	7.84	2.06	0.62	0.62	0.21	0.62	0.00	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	22.83	10.95	1.50	0.46	1.50	0.92	1.27	1.04	0.81	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	22.85	8.34	3.50	0.83	1.33	1.00	1.83	0.67	0.50	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	16.75	6.17	2.65	0.44	1.54	0.66	0.00	0.22	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	15.62	8.86	1.97	0.37	1.35	0.61	1.48	0.86	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	17.34	8.59	2.11	0.32	2.11	0.65	0.81	0.32	0.65	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	9.94	8.34	1.92	0.96	2.25	0.32	0.64	0.96	0.64	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	17.53	5.59	1.90	0.38	1.61	0.66	1.52	0.66	0.28	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	15.98	5.85	0.95	0.47	1.58	0.63	1.27	0.47	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	14.29	6.08	0.91	0.30	2.13	0.61	1.22	0.61	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	19.44	7.53	1.57	0.31	1.46	0.21	1.36	0.21	0.52	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	14.27	7.03	0.44	0.22	1.76	0.66	1.32	0.66	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	14.03	4.21	1.40	0.00	1.96	0.28	0.56	0.00	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	15.92	5.00	0.65	0.09	1.02	0.37	0.56	0.09	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	10.70	2.94	0.80	0.53	1.07	0.53	1.07	0.27	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	15.76	4.74	0.46	0.46	1.22	0.61	1.38	0.61	0.00	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	12.31	3.37	1.04	0.26	1.17	0.13	0.78	0.39	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	10.03	2.98	0.54	0.27	0.81	0.54	0.27	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	19.17	3.87	1.66	0.18	0.74	0.00	0.92	0.55	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	20.62	5.70	1.75	0.22	1.10	0.22	0.66	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	15.87	6.94	0.99	0.99	0.99	0.00	0.00	1.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	26.65	5.41	2.11	0.40	1.19	0.92	0.26	0.26	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	19.17	5.04	0.61	0.40	1.61	0.81	0.61	0.20	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	21.60	6.61	2.54	1.02	1.78	0.51	0.51	1.27	0.00	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	7.96	9.16	0.20	0.60	1.19	0.40	0.60	0.60	0.20	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	9.86	8.63	0.77	0.15	0.62	0.46	0.31	0.15	0.15	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	7.98	10.64	0.61	0.61	0.41	0.20	0.61	0.20	0.20	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	3.44	3.13	0.00	0.63	0.00	0.00	0.00	0.00	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	2.26	1.41	0.00	0.85	0.28	0.00	0.00	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	3.69	6.92	0.00	0.00	0.92	0.00	0.46	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	0.00	9.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	10.44	3.48	0.77	0.77	0.39	0.77	0.00	0.39	1.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	11.23	1.60	1.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	6.96	6.96	0.00	0.00	1.74	0.00	0.00	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	10.09	4.56	0.33	0.33	0.33	1.30	0.00	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	14.41	6.18	1.24	0.00	0.41	0.00	0.00	0.00	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	6.66	6.66	0.00	0.00	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	18.74	6.99	1.12	1.12	1.12	0.28	0.84	0.84	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	16.02	4.25	0.98	0.33	0.65	1.31	0.65	0.00	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	20.13	6.71	2.52	0.00	0.00	0.84	0.84	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	26.72	7.00	0.95	0.64	0.00	1.27	0.64	0.64	0.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	16.98	5.09	0.68	0.68	0.34	0.68	1.70	0.34	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	0.00	2.09	0.00	6.26	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	28.63	4.58	0.57	0.57	0.00	0.57	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	12.14	3.85	0.89	0.30	0.59	0.00	0.00	0.00	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	27.11	8.47	1.69	0.00	0.00	3.39	1.69	1.69	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	20.30	6.21	0.00	1.24	0.41	1.66	0.41	0.00	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	18.41	5.06	1.15	0.00	0.92	0.92	1.15	0.69	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	10.54	0.00	0.00	0.00	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	20.76	5.38	0.38	0.00	0.77	1.15	0.77	0.00	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	25.10	3.59	1.96	0.33	0.98	0.33	1.30	0.00	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	18.06	3.34	2.01	0.00	0.67	0.67	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	30.82	6.55	0.77	0.39	0.77	1.16	0.00	0.39	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	49.64	7.87	2.74	0.68	1.71	4.79	1.03	0.68	2.05	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	39.76	2.48	0.00	0.00	0.00	0.00	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	25.95	5.19	1.42	0.00	0.94	0.94	0.94	0.00	1.89	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	29.57	7.24	0.60	0.00	0.60	2.41	1.21	0.00	2.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	25.94	9.66	1.53	0.00	0.00	1.02	1.02	0.51	1.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	21.54	5.58	0.80	1.20	0.80	0.80	0.80	0.40	1.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	37.00	11.84	0.99	0.00	1.48	1.48	0.00	0.49	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	30.69	9.44	0.00	0.00	0.00	2.36	0.00	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	23.34	6.42	1.17	0.00	1.17	0.00	0.00	0.58	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	25.02	9.22	1.32	0.44	0.00	0.88	0.44	0.44	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	37.30	10.17	5.93	0.00	2.54	1.70	0.85	2.54	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	20.89	6.57	1.19	0.00	0.60	2.39	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	25.23	5.82	1.46	0.49	0.49	1.46	0.97	0.49	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	11.41	4.57	0.00	0.00	2.28	0.00	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	11.64	1.66	0.83	0.00	1.66	0.00	0.00	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	11.24	2.25	0.00	0.00	1.12	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	5.39	1.90	0.63	1.27	0.63	0.00	0.00	0.32	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.51	1.25	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	7.66	13.34	1.62	1.51	0.81	0.35	0.12	0.12	0.35	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	9.62	14.01	1.52	2.03	0.17	0.84	0.34	0.17	0.34	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	8.65	12.74	2.28	0.46	0.46	0.91	0.23	0.46	1.14	1.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	9.95	12.02	1.86	1.20	0.66	0.87	0.11	0.55	0.77	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	11.82	12.68	2.79	0.64	0.43	0.43	0.43	0.21	0.21	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	8.61	10.76	1.29	0.43	0.43	0.00	0.00	0.22	0.65	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	6.73	7.97	1.00	0.87	0.00	0.50	0.00	0.75	0.25	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	3.77	10.81	1.20	1.54	0.34	0.17	0.00	0.34	0.17	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	6.73	5.45	0.64	0.00	0.00	0.64	0.32	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	5.60	1.68	0.56	0.00	0.56	0.00	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.09	2.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	2.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	16.93	3.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.99	2.91	0.00	0.00	0.00	1.45	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	8.39	4.55	0.70	1.05	0.17	0.35	0.17	0.17	0.17	0.52
Hepatocyte, donor1	11523-119I2	7.26	3.63	0.00	3.63	0.00	0.00	0.00	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	20.47	7.54	0.00	2.15	0.00	1.08	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	11.04	6.14	0.61	0.00	0.00	0.00	0.61	0.00	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	255.20	135.76	37.20	7.18	7.18	7.83	14.36	20.89	7.83	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	21.32	11.89	1.92	1.75	0.35	0.87	0.17	0.87	0.35	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	22.09	5.49	1.23	0.82	0.96	0.55	0.41	0.14	0.55	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	0.00	0.00	0.00	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00	6.68	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	0.00	0.00	0.00	0.00	0.00	4.15	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	0.00	0.00	0.00	2.50	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	30.75	0.00	0.00	0.00	2.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	34.11	0.00	0.00	0.00	3.25	0.00	3.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	26.68	0.00	0.00	0.00	1.67	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	3.63	0.00	0.00	0.00	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	38.38	1.32	0.00	1.32	2.65	1.32	1.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	18.85	0.00	0.00	0.00	2.22	0.00	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00	0.00	0.00	5.24	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	27.08	0.00	0.00	0.00	1.26	1.26	1.89	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	23.20	0.00	0.00	0.00	1.55	0.00	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	24.55	0.00	0.65	0.00	0.65	0.65	1.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	24.15	0.00	0.00	0.00	1.61	0.00	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	27.71	0.00	0.00	0.00	2.44	2.44	1.63	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	28.97	0.42	0.00	0.00	1.68	1.26	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	29.74	0.00	0.00	0.00	1.61	1.61	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	15.70	0.00	0.00	0.92	1.85	0.92	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	16.99	0.94	0.00	0.00	0.94	2.36	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	23.58	0.00	0.00	0.00	0.91	0.00	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	23.67	0.00	0.00	0.00	4.30	0.00	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	20.33	0.00	0.00	0.00	0.00	5.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	19.77	0.64	0.00	0.00	1.28	0.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	14.58	0.00	0.00	0.00	1.82	0.00	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	17.14	0.00	0.00	0.00	0.71	0.00	0.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	46.46	0.00	0.00	0.00	0.00	3.32	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	18.21	1.23	0.00	0.00	1.85	0.31	0.62	0.00	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	21.07	0.00	0.00	0.00	0.00	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	29.21	1.39	0.00	0.00	1.39	1.39	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	28.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	35.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	24.41	0.00	0.00	0.00	0.87	0.87	1.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	15.75	0.00	0.00	0.00	6.75	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	22.40	0.00	0.00	0.00	2.13	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	26.32	1.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	39.89	0.00	0.00	0.00	0.00	0.00	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	27.61	0.92	0.00	0.00	1.84	1.84	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	27.23	0.00	0.00	3.03	3.03	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	0.00	0.00	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	15.86	1.06	0.00	0.00	2.11	3.17	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	108.53	4.90	0.65	0.41	2.28	3.10	1.14	0.73	1.14	0.24
Keratinocyte - epidermal, donor2	11349-117G8	20.50	0.59	0.00	0.00	0.00	1.17	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	63.42	3.50	0.57	0.19	0.95	2.08	0.19	0.09	0.28	0.00
Keratinocyte - oral, donor1	11251-116E9	76.51	2.95	0.45	0.23	1.70	1.36	0.23	0.11	0.79	0.34
Keratocytes, donor1	11527-119I6	9.97	3.44	0.69	0.69	0.00	0.69	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	8.20	1.17	0.00	0.00	0.00	2.34	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	6.32	4.35	0.79	0.40	0.00	0.20	0.00	0.20	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	37.36	74.73	2.20	4.40	0.00	0.00	2.20	0.00	0.00	4.40
Lens Epithelial Cells, donor1	11529-119I8	25.89	3.24	1.08	3.24	1.08	2.16	1.08	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	17.07	9.46	1.38	0.69	1.73	0.35	0.69	0.23	0.23	0.23
Lens Epithelial Cells, donor3	11690-122I7	67.31	9.28	1.31	0.91	1.51	2.22	1.21	0.30	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	7.59	2.49	0.24	0.24	0.47	0.24	0.12	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3.91	0.84	0.00	0.00	0.00	0.28	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	10.39	3.46	0.31	0.31	0.47	0.47	0.31	0.00	0.79	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	7.53	0.54	0.00	1.08	0.00	1.61	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.36	1.89	0.00	0.00	0.00	0.32	0.00	0.00	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	3.56	0.97	0.43	0.22	0.00	0.11	0.00	0.00	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	8.21	3.28	0.41	0.00	0.82	0.41	0.41	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	1.77	1.01	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4.50	1.69	0.14	0.42	0.14	0.14	0.00	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.12	3.56	0.00	0.40	0.40	0.00	0.00	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	5.04	2.91	0.19	0.19	0.39	0.58	0.00	0.19	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.41	1.30	0.00	0.19	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.06	3.48	0.35	0.00	0.35	0.70	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	2.15	2.15	0.24	0.48	0.24	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4.26	0.82	0.14	0.00	0.14	0.27	0.14	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	8.01	1.54	0.62	0.62	0.62	0.31	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.81	0.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	5.49	1.10	0.00	0.18	0.18	0.37	0.00	0.18	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	8.89	2.96	0.33	0.00	0.00	0.00	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.64	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	3.73	2.24	0.25	0.75	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	12.61	1.94	0.00	0.48	0.00	0.00	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	4.04	1.89	0.00	0.00	0.00	0.81	0.00	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	6.21	1.97	0.15	0.00	0.00	0.15	0.00	0.00	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.26	1.04	0.00	0.52	0.00	0.52	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.12	1.88	0.84	0.21	0.21	0.21	0.00	0.00	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.81	2.71	0.15	0.45	0.15	0.00	0.45	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	7.57	2.06	0.69	0.00	1.38	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	3.39	2.45	0.00	0.19	0.00	0.00	0.00	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	2.86	0.95	0.00	0.11	0.11	0.42	0.21	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.21	3.39	0.48	0.00	0.48	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	1.98	0.99	0.33	0.33	0.00	0.66	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2.73	1.49	0.12	0.37	0.12	0.00	0.12	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	12.96	4.81	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	4.45	1.24	0.00	0.00	0.25	0.00	0.25	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	2.47	0.69	0.27	0.00	0.14	0.00	0.00	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	12.54	3.54	0.00	0.32	0.00	0.00	0.32	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7.30	3.35	0.61	0.30	0.00	0.00	0.30	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.98	3.64	0.28	0.14	0.42	0.56	0.00	0.14	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	9.24	2.13	0.00	0.36	0.71	0.36	0.00	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	2.42	0.97	0.00	0.00	0.00	0.97	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	2.33	0.78	0.00	0.16	0.16	0.16	0.00	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.09	2.15	0.72	0.36	0.00	0.00	0.00	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	2.94	3.27	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	1.65	0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	5.45	1.86	0.00	0.25	0.12	0.00	0.25	0.00	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	2.31	0.51	0.00	0.51	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	2.39	0.90	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	0.00	13.60	2.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	0.00	3.84	1.53	1.53	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	0.00	8.91	1.48	0.74	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	0.00	8.46	0.42	0.85	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	0.00	0.70	0.70	0.70	0.00	0.00	0.00	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	0.00	0.93	0.00	1.87	0.00	0.00	0.00	0.93	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	0.00	5.67	0.00	0.52	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	0.00	2.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	0.00	3.62	0.23	1.36	0.00	0.00	0.00	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	0.00	7.85	1.45	1.74	0.00	0.00	0.00	0.00	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	0.00	4.95	1.35	0.45	0.00	0.00	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	0.00	7.72	0.41	0.68	0.00	0.00	0.00	0.00	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	0.00	5.14	1.03	0.51	0.00	0.00	0.00	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	0.00	2.82	1.06	0.35	0.00	0.00	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	0.00	5.33	0.67	0.67	0.00	0.00	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	0.00	9.17	1.53	1.53	0.00	0.00	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	0.00	5.87	1.33	1.07	0.00	0.00	0.00	0.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	0.00	6.99	0.38	1.13	0.00	0.00	0.00	0.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	0.00	4.91	0.61	0.61	0.00	0.00	0.00	0.00	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	0.00	4.08	0.00	0.00	0.00	0.00	0.00	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	0.00	6.66	1.87	1.04	0.00	0.00	0.00	0.42	0.21	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	0.00	5.89	1.40	0.28	0.00	0.00	0.00	0.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	0.00	5.15	1.03	1.03	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	0.00	4.64	0.29	0.58	0.00	0.00	0.00	0.87	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	0.00	6.58	1.20	0.90	0.00	0.00	0.00	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	0.00	8.30	1.11	0.00	0.00	0.00	0.00	0.55	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	0.00	7.78	1.77	0.00	0.00	0.00	0.00	0.00	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	0.00	6.64	1.84	0.37	0.00	0.00	0.00	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	0.00	5.76	2.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	0.00	4.99	1.15	0.00	0.00	0.00	0.00	0.77	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	0.00	3.40	0.00	1.13	0.00	0.00	0.00	0.57	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	0.00	7.38	0.00	0.82	0.00	0.00	0.00	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	0.00	6.33	0.45	0.45	0.00	0.00	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	0.00	4.31	1.44	1.44	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	0.00	7.47	1.49	0.75	0.00	0.00	0.00	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	0.00	11.52	1.49	0.37	0.00	0.00	0.00	0.37	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	0.00	8.18	0.43	0.43	0.00	0.00	0.00	0.86	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	0.00	6.85	1.71	0.86	0.00	0.00	0.00	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	0.00	4.00	1.67	1.33	0.00	0.00	0.00	0.67	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	0.00	1.81	2.41	1.21	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	0.00	5.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	0.00	5.84	1.03	0.34	0.00	0.00	0.00	0.00	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	0.00	2.15	2.15	0.54	0.00	0.00	0.00	0.00	0.00	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	0.00	10.10	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	0.00	5.56	0.00	0.00	0.00	0.00	0.00	0.37	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	0.00	6.98	0.00	1.16	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	0.00	2.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	0.00	6.40	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	0.00	5.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	0.00	6.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	0.00	7.40	0.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	0.00	2.82	0.00	0.00	0.00	0.00	0.00	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	0.00	7.04	0.50	1.51	0.00	0.00	0.00	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	0.00	7.21	0.45	1.35	0.00	0.00	0.00	0.00	0.00	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	5.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	0.00	5.34	0.00	2.23	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	0.00	6.65	0.78	1.56	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	0.00	4.62	2.64	0.66	0.00	0.00	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	0.00	3.63	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	0.00	10.94	1.31	0.88	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	0.00	8.95	0.00	0.56	0.00	0.00	0.00	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	0.00	4.42	0.00	0.44	0.00	0.00	0.00	0.88	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	0.00	8.87	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	0.00	4.05	0.51	0.51	0.00	0.00	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	0.00	7.69	0.00	0.00	0.00	0.00	0.00	0.96	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	0.00	7.16	0.40	0.40	0.00	0.00	0.00	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	0.00	7.29	0.00	0.61	0.00	0.00	0.00	0.00	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	0.00	6.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	0.00	3.80	0.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	0.00	3.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	0.00	4.23	0.60	2.42	0.00	0.00	0.00	0.00	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	0.00	6.65	0.95	0.95	0.00	0.00	0.00	0.32	0.32	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	0.00	3.73	2.13	0.53	0.00	0.00	0.00	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	0.00	4.02	0.57	1.15	0.00	0.00	0.00	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	0.00	4.11	2.06	1.03	0.00	0.00	0.00	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	0.00	5.66	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	0.00	4.54	0.00	0.57	0.00	0.00	0.00	0.57	0.00	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	0.00	6.66	0.00	0.83	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	0.00	8.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	0.00	7.52	0.84	0.00	0.00	0.00	0.00	0.00	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	0.00	4.18	0.00	0.93	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	0.00	8.03	0.67	0.67	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	0.00	6.95	0.53	0.00	0.00	0.00	0.00	0.00	0.00	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	0.00	5.66	1.21	1.21	0.00	0.00	0.00	0.40	0.00	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	0.00	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	0.00	8.00	1.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	0.00	10.83	0.57	1.71	0.00	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	0.00	9.97	3.07	0.77	0.00	0.00	0.00	0.00	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	0.00	8.21	1.09	2.19	0.00	0.00	0.00	0.00	0.00	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	0.00	7.57	0.45	2.23	0.00	0.00	0.00	0.00	0.00	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	0.00	9.88	0.78	0.52	0.00	0.00	0.00	0.26	0.00	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	0.00	8.62	0.00	0.66	0.00	0.00	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	0.00	8.31	0.00	4.16	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	4.33	9.34	0.68	3.19	0.46	0.00	0.00	0.91	0.68	1.14
Macrophage - monocyte derived, donor2	11313-117C8	0.92	2.20	0.00	2.39	0.37	0.00	0.00	0.37	0.18	0.18
Macrophage - monocyte derived, donor3	11389-118C3	3.80	5.90	0.66	2.36	0.66	0.00	0.13	0.13	0.26	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	45.67	3.72	0.00	1.59	2.66	1.59	0.53	0.00	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	104.42	4.91	1.27	0.79	0.95	5.70	1.43	0.95	1.27	0.00
Mallassez-derived cells, donor3	11930-125I4	61.43	2.50	0.83	0.97	1.67	2.36	0.69	0.28	0.42	0.14
Mammary Epithelial Cell, donor1	11273-116H4	69.95	3.79	0.20	0.20	0.90	2.09	0.50	0.10	1.40	0.30
Mammary Epithelial Cell, donor2	11350-117G9	51.83	2.32	0.29	0.29	0.29	1.45	0.87	0.00	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	20.95	1.00	0.00	0.25	0.25	0.50	0.25	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	176.94	42.03	5.42	6.78	2.03	4.07	5.42	1.36	2.71	0.00
Mast cell, donor1	11563-120D6	127.28	37.52	6.81	2.81	5.62	3.35	3.78	2.27	1.19	0.87
Mast cell, donor2	11565-120D8	80.53	15.45	2.38	1.78	5.65	1.49	0.89	1.78	0.59	0.59
Mast cell, donor3	11566-120D9	101.53	17.11	1.58	1.80	4.28	1.13	2.03	2.03	0.23	0.90
Mast cell, donor4	11567-120E1	82.79	15.25	0.89	0.89	5.85	1.60	1.06	0.89	0.35	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	115.22	30.05	3.88	1.77	5.54	2.33	2.00	0.67	0.33	1.33
Mast cell, expanded and stimulated, donor8	11942-126A7	66.54	8.76	4.09	2.33	5.84	2.92	2.33	0.00	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	86.04	23.40	2.64	2.06	5.39	1.03	1.49	0.46	0.23	0.80
Mast cell, expanded, donor8	11941-126A6	71.97	19.92	1.17	1.51	3.68	1.00	0.67	0.50	0.17	0.33
Melanocyte - dark, donor1	11502-119F8	8.66	1.99	0.20	0.10	0.30	0.00	0.40	0.00	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	11.77	6.58	2.42	1.04	1.04	1.04	0.35	0.35	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	2.97	1.74	0.36	0.51	0.58	0.00	0.07	0.00	0.07	0.22
Melanocyte - light, donor1	11274-116H5	3.29	2.35	0.00	0.24	0.47	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	2.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.36
Melanocyte - light, donor3	11423-118G1	0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	6.77	3.64	0.21	0.83	0.94	0.10	0.00	0.10	0.21	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	3.23	2.96	0.00	0.54	0.00	0.00	0.00	0.00	0.54	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	6.16	4.29	0.54	0.27	0.54	0.27	0.54	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	24.69	4.84	0.87	1.61	1.61	0.74	0.50	0.25	0.00	0.12
Meningeal Cells, donor2	11573-120E7	12.32	5.28	1.76	0.88	0.00	0.00	0.88	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	35.13	6.52	1.22	1.14	1.87	0.82	0.73	0.49	0.33	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	8.27	3.42	0.86	0.29	0.57	0.29	0.00	0.00	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	23.15	6.84	1.21	2.11	1.31	0.50	0.00	0.91	0.50	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	19.38	6.46	1.44	0.72	0.72	0.00	0.00	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	9.53	2.75	0.85	0.21	0.85	0.00	0.00	0.21	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	6.53	2.51	0.00	1.51	0.00	0.00	0.00	0.00	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	8.79	1.76	0.66	0.22	0.88	0.44	0.44	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	2.92	3.65	0.00	0.73	0.00	0.00	0.00	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	8.18	3.27	0.20	0.41	0.20	0.20	0.00	0.00	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	13.30	0.83	0.28	0.14	1.11	0.14	0.00	0.00	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	2.97	1.86	0.00	0.37	0.37	0.00	0.00	0.37	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	4.74	6.58	0.79	2.24	0.39	0.00	0.00	0.26	0.13	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	1.78	1.48	0.30	0.00	0.59	0.00	0.00	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	3.20	2.56	0.00	1.92	0.64	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	23.39	7.44	0.00	0.35	0.35	0.35	0.00	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	4.69	6.57	0.94	1.56	0.31	0.00	0.00	0.00	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	2.90	2.90	0.00	0.73	1.45	0.00	0.00	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	46.67	9.02	0.80	1.86	1.06	1.33	0.53	0.27	0.53	0.80
Mesothelial Cells, donor2	12156-128G5	43.04	3.50	1.00	1.00	1.00	0.50	0.50	0.50	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	47.77	8.82	1.08	1.66	0.94	0.94	1.08	0.51	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	4.05	1.35	0.00	5.40	1.35	0.00	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	3.20	7.14	0.99	2.71	0.74	0.00	0.00	1.23	0.25	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	2.06	6.48	0.29	2.65	0.29	0.00	0.00	0.00	0.29	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	6.91	3.46	3.46	0.00	0.00	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	2.79	3.72	0.31	2.48	0.00	0.00	0.31	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	3.11	2.49	1.24	1.24	0.41	0.00	0.00	0.62	1.04	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	4.63	0.00	0.00	0.00	0.00	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	7.26	8.51	0.75	2.25	0.50	0.00	0.00	1.75	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.05	6.52	0.47	1.86	0.00	0.00	0.47	0.00	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	3.05	3.86	0.41	1.22	0.00	0.00	0.20	0.81	0.00	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	4.36	4.75	0.79	1.19	1.19	0.40	0.40	0.79	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	34.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.08	1.77	0.00	1.77	0.00	0.00	0.00	1.77	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	2.66	3.04	0.00	2.28	0.00	0.00	0.76	0.00	0.00	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	6.58	0.00	6.58	0.00	0.00	1.32	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	5.52	4.67	1.49	1.27	0.21	0.21	1.06	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1.84	4.60	0.00	5.52	0.00	0.00	0.92	2.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	2.68	5.37	0.00	3.87	0.30	0.00	1.49	0.89	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	5.03	1.68	3.35	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	33.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.28	6.02	1.00	3.01	0.25	0.25	0.75	0.50	1.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	3.80	3.80	0.00	2.38	0.71	0.00	0.00	0.71	0.71	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.32	7.19	1.11	3.32	1.11	0.00	0.55	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	4.37	5.07	0.92	1.84	0.92	0.23	1.61	0.69	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	2.94	5.68	0.84	2.10	0.42	0.00	0.00	0.42	0.63	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.71	4.89	0.61	1.83	0.41	0.00	0.61	0.20	0.20	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.43	4.08	1.50	2.36	0.21	0.00	0.43	1.07	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	1.56	3.33	0.44	1.78	0.22	0.00	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	10.32	0.00	0.00	0.00	0.00	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	3.07	3.94	1.10	3.07	0.22	0.00	0.66	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	1.52	2.53	1.01	2.03	0.00	0.00	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	4.97	0.00	1.66	0.00	0.00	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	3.26	3.26	1.63	1.90	0.27	0.27	0.54	0.54	0.54	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	1.18	3.23	0.29	1.18	0.29	0.00	0.00	0.00	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	2.18	0.00	5.45	0.00	0.00	0.00	2.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.48	2.40	0.48	0.96	0.00	0.00	0.48	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	1.20	3.20	0.00	1.60	0.00	0.00	0.40	0.80	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	1.37	0.00	2.74	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.00	2.50	0.50	1.50	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	0.00	2.04	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	0.00	0.88	0.00	1.31	0.00	0.00	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	0.00	0.00	3.31	0.00	1.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.00	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	1.74	0.50	0.50	0.50	0.00	0.00	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.00	0.70	0.70	0.70	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	0.00	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.44	0.44	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1.07	0.00	0.36	0.00	0.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	0.84	0.56	0.00	0.28	0.00	0.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	0.83	1.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	0.60	0.30	0.00	0.60	0.00	0.00	0.00	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	0.00	0.83	0.42	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.00	1.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1.71	1.71	0.57	0.57	0.00	0.00	0.00	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	0.55	0.97	0.28	0.83	0.00	0.00	0.00	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	0.26	1.04	0.26	0.52	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	0.86	1.29	0.00	0.00	0.00	0.00	0.00	0.43	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.64	0.64	0.00	0.64	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	0.27	0.53	0.00	0.00	0.00	0.00	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	2.10	2.10	0.00	0.90	0.30	0.00	0.00	1.20	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	0.28	0.85	0.00	0.14	0.00	0.00	0.00	0.42	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	1.27	0.64	0.00	0.32	0.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	1.11	1.11	0.00	0.88	0.00	0.00	0.22	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	0.38	1.14	0.00	0.38	0.00	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	0.57	0.28	0.28	0.00	0.00	0.00	0.00	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	0.25	1.97	0.00	0.25	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.00	0.65	0.00	0.00	0.00	0.00	0.00	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	0.88	0.59	0.29	0.88	0.29	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	1.44	3.75	0.58	0.86	0.00	0.00	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	1.24	2.06	0.00	1.65	0.41	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	1.19	2.08	0.30	1.79	0.30	0.00	0.00	0.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	1.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	1.97	3.29	0.99	1.97	0.00	0.33	0.33	0.33	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	0.00	1.05	0.00	2.10	0.00	0.00	1.05	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	2.57	2.37	0.59	1.98	0.20	0.00	0.00	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	3.73	8.38	0.00	3.73	0.93	0.00	0.00	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	3.38	4.13	0.00	1.50	0.00	0.00	0.38	1.88	0.00	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	1.86	2.66	0.27	1.86	0.53	0.00	0.00	0.00	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	1.47	1.13	0.23	0.68	0.00	0.00	0.00	0.45	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	3.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	0.73	1.83	1.10	0.73	0.73	0.00	0.00	0.37	0.37	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	3.11	3.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.21	1.60	0.00	1.60	0.00	0.00	0.00	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	3.03	1.01	2.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.42	2.95	0.00	1.26	0.00	0.00	0.00	0.00	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	4.09	0.00	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	1.91	0.00	1.91	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.81	1.62	1.62	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	1.51	0.00	1.51	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	17.13	0.00	5.71	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	0.00	3.26	6.52	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	47.18	8.40	1.72	0.43	0.65	1.29	0.86	0.43	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	16.20	4.18	1.57	2.61	0.00	0.00	0.00	0.52	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	11.35	2.67	0.00	0.00	0.67	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.01	0.00	0.42	0.00	0.42	0.00	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	18.25	5.13	2.85	0.19	0.38	0.19	0.76	0.19	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	22.34	14.36	1.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.76	2.04	0.00	0.68	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	7.35	1.84	0.00	0.00	1.84	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	4.60	1.67	0.00	0.00	0.42	0.00	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	7.90	2.79	0.46	0.93	0.46	0.23	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	7.84	1.08	0.54	0.54	0.00	0.27	0.00	0.00	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	13.67	4.63	1.05	1.05	1.05	0.00	0.63	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13	22.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	8.44	3.47	0.50	0.50	0.99	0.00	0.00	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	8.93	2.98	1.89	0.27	0.54	0.00	0.27	0.54	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.25	0.91	0.00	1.13	0.00	0.23	0.45	0.00	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	5.88	1.80	0.16	0.16	0.33	0.33	0.16	0.00	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	11.30	4.92	0.91	0.55	1.82	0.00	0.18	0.00	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	11.14	2.65	0.53	0.53	0.00	0.00	0.53	0.00	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.60	1.80	0.60	0.00	0.00	0.00	1.20	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	9.85	4.92	0.98	1.31	0.00	0.00	0.00	0.00	1.31	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	9.76	1.79	0.33	0.33	0.49	0.16	0.16	0.00	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	17.64	6.00	0.88	0.71	1.06	0.71	0.35	0.71	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.85	0.70	0.00	2.11	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	7.82	0.92	0.92	0.46	0.46	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	7.39	2.57	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	16.55	5.52	1.03	0.00	0.34	0.00	0.34	0.34	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	45.51	5.06	10.11	0.00	0.00	0.00	0.00	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	16.26	4.68	1.34	0.22	0.67	0.00	0.00	0.00	0.67	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	11.85	0.85	0.42	0.00	2.12	0.00	0.85	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	12.58	2.14	0.95	0.47	0.00	0.24	0.00	0.47	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	12.88	3.00	0.00	0.43	0.00	0.00	0.00	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00	9.03	0.00	0.00	0.00	0.00	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.00	3.33	0.33	0.33	1.33	0.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	17.13	3.61	1.35	0.45	0.90	0.45	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	9.52	2.38	0.00	1.59	0.00	0.00	0.79	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	8.36	2.79	0.93	0.93	0.93	0.00	0.00	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	14.00	5.68	0.00	0.38	1.14	0.38	0.76	0.00	0.00	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	14.99	4.24	0.98	1.96	1.63	0.33	0.65	0.33	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	5.23	1.31	0.44	0.44	0.87	0.00	0.00	0.00	0.00	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	23.07	5.43	0.45	1.36	0.90	1.36	0.00	0.00	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	10.58	2.65	0.00	0.88	0.00	0.00	2.65	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	7.31	0.66	0.00	0.00	1.99	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	9.92	3.47	0.00	0.99	0.00	0.00	0.50	0.00	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.10	1.15	0.38	0.77	0.38	0.38	0.77	0.00	1.15	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	16.63	3.33	0.30	0.60	0.60	0.00	0.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	21.00	5.97	1.33	1.55	0.66	0.22	0.66	0.00	1.55	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	7.45	0.68	0.68	0.68	1.36	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	15.33	0.00	0.00	0.00	0.00	10.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	8.54	1.83	0.00	0.61	1.22	0.00	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	13.53	2.52	0.31	0.31	0.63	0.31	0.63	0.31	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.36	1.21	0.00	0.30	0.91	0.00	0.00	0.00	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	15.03	3.16	0.00	0.79	0.00	1.58	0.79	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	10.20	5.67	1.13	1.13	0.00	0.00	1.13	1.13	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	25.96	5.22	1.24	1.86	1.24	0.50	0.37	0.37	0.37	0.12
Myoblast, donor2	11322-117D8	20.14	7.67	0.96	1.53	0.77	0.58	0.38	0.19	0.38	0.00
Myoblast, donor3	11398-118D3	20.35	7.57	1.35	2.19	1.35	0.67	0.00	0.17	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	45.68	25.83	4.38	2.19	1.90	2.04	0.29	0.44	1.02	1.02
Natural Killer Cells, donor1	11230-116C6	34.75	9.84	0.31	3.69	2.15	0.31	0.00	1.23	0.31	0.62
Natural Killer Cells, donor2	11311-117C6	20.20	6.63	0.00	3.62	0.60	0.00	0.90	0.00	0.60	1.21
Natural Killer Cells, donor3	11387-118C1	26.50	8.65	1.29	2.94	1.66	0.55	0.00	0.18	0.55	0.00
Neural stem cells, donor1	11275-116H6	13.79	35.93	4.36	5.08	1.09	0.36	1.09	3.63	0.36	1.09
Neural stem cells, donor2	11352-117H2	15.41	25.03	3.85	5.78	0.00	0.00	0.00	5.78	1.93	0.00
Neurons, donor1	11494-119E9	2.28	13.65	2.28	2.28	0.00	0.00	0.00	1.14	1.14	0.00
Neurons, donor2	11574-120E8	5.72	10.57	1.54	0.44	0.66	0.00	0.00	0.44	0.22	0.44
Neurons, donor3	11655-122E8	3.29	7.40	1.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	0.93	2.78	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.93
Neutrophils, donor2	11314-117C9	8.70	2.90	0.00	2.90	0.00	0.00	0.00	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	4.89	2.44	0.61	0.00	0.00	0.00	0.00	0.61	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	16.27	4.75	0.36	1.66	0.95	0.36	0.12	0.00	0.24	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	2.60	1.95	0.00	0.33	0.00	0.00	0.00	0.00	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	4.61	0.80	0.20	0.60	0.40	0.20	0.00	0.00	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	7.85	3.03	0.41	1.10	0.55	0.28	0.00	0.14	0.41	0.00
Olfactory epithelial cells, donor2	11934-125I8	11.15	3.91	1.45	1.74	0.14	0.43	0.00	0.29	0.43	0.14
Olfactory epithelial cells, donor3	11935-125I9	18.39	6.02	1.25	1.25	1.14	0.11	0.34	0.00	0.79	0.23
Olfactory epithelial cells, donor4	11936-126A1	21.43	5.94	0.10	1.46	0.68	0.10	0.29	0.00	0.88	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	24.67	7.82	0.00	1.81	0.00	1.20	0.60	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	12.76	3.83	1.06	0.21	0.43	0.00	0.21	0.21	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	3.43	0.00	0.00	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	6.83	2.48	0.00	0.62	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	3.52	0.59	0.00	0.39	0.00	0.20	0.00	0.00	0.00	0.20
Osteoblast, donor2	11354-117H4	40.03	5.62	1.40	0.70	0.70	3.51	0.00	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	25.42	4.98	1.78	1.07	1.24	0.18	0.36	0.18	0.00	0.53
Pancreatic stromal cells, donor1	11249-116E7	25.19	4.55	1.26	1.01	1.26	0.84	0.08	0.08	0.08	0.08
Pericytes, donor1	11491-119E6	1.67	1.11	0.33	0.00	0.33	0.00	0.11	0.00	0.00	0.22
Pericytes, donor2	11571-120E5	2.94	1.36	0.45	0.00	0.00	0.00	0.45	0.00	0.23	0.00
Pericytes, donor3	11652-122E5	10.17	3.26	1.22	0.81	0.61	0.20	0.41	0.00	0.20	0.20
Perineurial Cells, donor1	11499-119F5	26.22	5.54	0.90	0.23	1.36	0.79	0.45	0.34	0.23	0.23
Perineurial Cells, donor2	11579-120F4	17.85	8.74	0.92	1.20	0.64	0.37	0.37	0.37	0.18	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	31.24	13.07	0.64	2.87	1.91	0.32	0.32	0.00	0.32	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	19.10	9.06	0.98	1.22	0.24	0.24	0.00	1.47	0.73	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	18.77	6.86	0.52	0.78	0.52	0.39	0.65	0.13	0.26	0.52
Placental Epithelial Cells, donor1	11278-116H9	16.26	1.43	0.48	0.00	0.24	0.00	0.00	0.96	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	18.85	0.00	0.00	0.00	0.00	0.00	0.00	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	14.53	1.77	0.00	0.20	0.39	0.00	0.00	0.39	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	10.76	1.58	0.63	1.90	0.32	0.00	0.00	0.00	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	9.00	1.88	0.56	1.69	0.94	0.00	0.19	0.19	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	22.06	5.22	1.57	2.35	1.44	0.52	0.52	0.00	0.26	0.39
Preadipocyte - breast, donor2	11328-117E5	4.95	4.28	0.68	0.90	0.45	0.00	0.00	0.23	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	8.74	4.16	0.85	1.81	0.75	0.11	0.11	0.53	0.53	0.32
Preadipocyte - omental, donor2	11329-117E6	11.35	1.31	0.87	1.31	0.87	0.44	0.00	0.44	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	15.18	5.16	0.43	1.43	0.72	0.00	1.15	0.43	0.14	0.00
Preadipocyte - perirenal, donor1	11469-119C2	3.94	2.95	1.97	0.98	0.00	0.00	0.00	1.97	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	11.98	3.99	0.31	0.00	0.92	0.61	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	15.76	5.14	0.35	1.77	0.35	0.18	0.00	0.00	0.53	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	8.17	1.87	0.51	0.51	1.02	0.00	0.17	0.17	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	10.99	3.17	0.65	1.49	1.21	0.47	0.19	0.09	0.09	0.00
Preadipocyte - visceral, donor2	11357-117H7	8.28	1.84	0.46	2.30	0.92	1.38	0.00	0.46	0.00	0.92
Preadipocyte - visceral, donor3	11429-118G7	7.21	1.57	0.52	1.15	0.52	0.10	0.00	0.10	0.42	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	31.68	6.64	2.72	0.60	0.45	1.21	0.30	0.60	0.15	0.30
Prostate Epithelial Cells, donor2	11331-117E8	46.58	2.98	0.41	0.95	0.81	1.49	0.27	0.14	1.76	0.00
Prostate Epithelial Cells, donor3	11404-118D9	23.21	2.88	0.12	0.12	0.61	0.12	0.18	0.00	0.31	0.06
Prostate Stromal Cells, donor1	11254-116F3	4.21	5.24	0.34	0.91	0.00	0.00	0.11	0.23	0.46	0.11
Prostate Stromal Cells, donor2	11332-117E9	12.19	6.63	0.90	1.43	0.90	0.72	0.00	0.18	0.54	0.18
Prostate Stromal Cells, donor3	11405-118E1	11.99	4.90	1.15	0.83	0.42	0.52	0.31	0.42	0.21	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	13.50	3.65	0.73	0.36	0.00	0.00	0.00	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	40.13	11.37	1.52	0.28	1.52	0.62	0.55	0.42	0.21	0.55
Renal Epithelial Cells, donor1	11517-119H5	29.42	6.59	1.01	0.51	0.51	2.03	0.00	1.01	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	17.07	9.25	0.00	0.71	1.42	0.71	0.00	0.71	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	69.24	23.40	2.96	0.53	2.01	3.18	0.64	1.06	0.74	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.77	2.72	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.14	1.08	0.13	0.13	0.54	0.00	0.00	0.00	0.67	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	31.53	9.99	2.00	1.11	0.67	1.55	0.67	1.11	1.33	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	0.67	2.00	0.00	0.00	0.00	0.00	0.00	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	10.78	5.50	0.22	0.44	0.44	0.22	0.66	0.22	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	13.17	6.90	0.00	0.63	0.00	0.00	1.25	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	5.83	3.33	0.83	0.28	0.28	0.00	0.00	0.00	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	26.57	7.25	0.81	0.54	0.81	0.81	0.00	0.00	0.54	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.90	2.95	0.00	0.00	0.42	0.84	0.00	0.00	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	18.51	8.68	0.77	0.39	0.58	0.58	0.39	0.00	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	11.93	5.96	1.04	0.52	0.78	0.78	0.00	0.26	0.52	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	7.67	0.85	0.85	0.85	0.00	0.28	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2.06	1.03	1.03	1.03	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	7.03	1.51	1.25	0.00	1.00	0.00	0.00	0.25	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	25.66	12.83	1.07	2.14	0.94	0.27	0.27	0.27	0.53	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	0.00	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	0.91	2.21	0.00	0.26	0.13	0.00	0.00	0.26	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	0.20	0.99	0.00	0.10	0.00	0.10	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	0.11	1.34	0.22	0.33	0.00	0.00	0.00	0.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	2.11	2.98	0.37	0.25	0.25	0.00	0.12	0.12	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	0.47	1.52	0.12	0.12	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	0.23	1.39	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	0.55	2.60	0.27	0.14	0.14	0.14	0.00	0.41	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	0.61	2.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	0.18	1.79	0.00	0.18	0.36	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	1.58	1.72	0.14	0.29	0.14	0.00	0.00	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	0.54	0.86	0.21	0.00	0.21	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	0.66	1.33	0.00	0.00	0.22	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	0.76	2.49	0.19	0.19	0.38	0.00	0.00	0.00	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	0.84	1.21	0.09	0.19	0.00	0.00	0.00	0.09	0.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	0.56	1.13	0.00	0.19	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	0.66	3.32	0.27	0.00	0.13	0.00	0.00	0.13	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	0.49	1.36	0.10	0.19	0.00	0.10	0.00	0.00	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	0.00	0.38	0.19	0.00	0.19	0.00	0.00	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	0.75	1.82	0.11	0.32	0.32	0.21	0.00	0.00	0.11	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	0.28	1.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	0.34	0.85	0.17	0.17	0.17	0.00	0.00	0.00	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	0.73	1.82	0.18	0.18	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	0.61	1.47	0.12	0.12	0.00	0.00	0.00	0.12	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	0.27	0.94	0.00	0.27	0.13	0.00	0.00	0.00	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	0.24	3.30	0.24	0.47	0.00	0.00	0.00	0.00	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	0.00	0.99	0.40	0.20	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	0.47	1.87	0.00	0.23	0.00	0.00	0.00	0.00	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	0.83	1.45	0.62	0.62	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	0.44	1.55	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	0.42	1.88	0.21	0.00	0.21	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	2.02	2.56	0.54	0.54	0.00	0.00	0.00	0.00	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	0.51	2.21	0.34	0.00	0.00	0.00	0.00	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	0.58	0.77	0.19	0.19	0.00	0.00	0.00	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	1.72	2.06	0.00	0.34	0.17	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	0.55	1.92	0.14	0.14	0.00	0.00	0.00	0.14	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	0.33	1.15	0.16	0.16	0.00	0.00	0.00	0.33	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	1.70	3.07	0.34	0.00	0.00	0.00	0.17	0.00	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	0.30	2.22	0.00	0.44	0.00	0.00	0.00	0.15	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	0.00	1.87	0.00	0.00	0.27	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	0.69	1.24	0.14	0.28	0.28	0.00	0.28	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	0.71	0.95	0.00	0.00	0.24	0.00	0.00	0.00	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	0.60	1.01	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	0.28	0.75	0.00	0.00	0.09	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	0.35	0.70	0.00	0.00	0.35	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	0.24	1.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	0.00	1.89	0.29	0.00	0.15	0.00	0.00	0.00	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	0.61	0.61	0.00	0.61	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	0.30	0.60	0.00	0.00	0.30	0.00	0.00	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	0.23	1.58	0.23	0.00	0.23	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	0.60	1.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	0.71	0.94	0.24	0.12	0.00	0.00	0.00	0.00	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	0.85	0.64	0.00	0.21	0.21	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	0.00	0.00	0.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	6.77	2.26	0.19	0.19	0.38	0.19	0.19	0.00	0.00	0.19
Schwann Cells, donor2	11578-120F3	13.61	0.00	0.00	0.00	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	14.90	4.60	0.22	1.53	1.10	0.22	0.22	0.22	0.44	0.00
Sebocyte, donor1	11220-116B5	43.82	3.83	0.00	0.55	0.00	1.64	2.19	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	34.47	1.84	0.00	0.00	0.46	1.38	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	8.04	0.82	0.21	0.00	0.21	0.00	0.00	0.00	0.00	0.21
Sertoli Cells, donor1	11255-116F4	11.60	6.63	0.00	6.63	0.00	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	14.12	11.30	2.82	5.65	0.00	2.82	0.00	0.00	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	25.25	7.13	1.32	0.97	0.88	0.88	0.79	0.26	0.26	0.18
Skeletal Muscle Cells, donor2	11358-117H8	2.17	0.72	0.00	0.00	0.72	0.00	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	22.57	5.02	1.67	0.84	0.00	0.00	2.51	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	16.49	10.21	2.36	0.94	1.10	0.79	0.31	0.16	0.79	0.79
Skeletal Muscle Cells, donor5	11455-119A6	19.92	8.47	1.49	1.93	1.19	0.89	0.15	0.15	0.89	0.30
Skeletal Muscle Cells, donor6	11459-119B1	36.63	13.70	2.31	1.69	1.85	0.15	0.92	0.31	1.23	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	20.54	8.32	2.52	2.02	0.88	1.01	0.25	0.50	0.00	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.12	7.99	1.14	1.85	1.14	0.43	0.14	0.00	0.29	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	23.41	12.60	2.28	1.69	1.19	0.99	0.69	0.40	0.40	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	18.70	5.90	0.76	0.34	1.43	0.25	0.51	0.25	0.34	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	17.37	3.62	0.72	0.00	0.72	0.72	0.72	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	4.27	1.93	0.55	0.28	0.41	0.14	0.28	0.14	0.41	0.14
Skin - palm, donor1	10286-104F7	21.49	0.00	5.37	2.69	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	48.29	1.87	0.58	0.72	0.29	1.15	1.30	0.14	0.43	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	280.54	4.91	1.64	2.45	0.82	10.63	3.27	0.00	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	35.83	2.21	0.65	0.26	0.78	1.69	0.39	0.13	0.13	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	39.48	2.09	0.28	0.56	0.97	0.83	0.42	0.00	0.56	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	49.65	1.55	0.00	0.14	0.84	1.83	1.13	0.00	0.98	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	243.37	9.09	2.33	1.27	7.61	5.07	1.27	1.06	0.42	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	27.96	2.77	0.00	0.15	0.30	0.67	0.45	0.00	0.22	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	10.80	2.16	0.00	0.31	0.62	0.62	0.00	0.00	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.68	4.45	0.89	1.11	0.89	0.44	0.00	0.00	0.44	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	12.34	7.05	1.18	0.00	0.59	0.00	0.00	0.59	0.00	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	9.72	4.86	0.66	0.44	0.66	0.22	0.00	0.00	0.22	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	5.51	1.18	0.39	0.39	0.00	0.39	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	11.59	6.95	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	6.00	8.01	0.00	1.00	1.00	0.00	0.00	0.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	21.69	3.06	0.53	0.53	0.53	0.67	0.13	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	7.09	1.11	0.89	1.33	0.44	0.00	0.22	0.44	0.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	21.38	3.84	0.13	0.77	1.15	0.38	0.26	0.38	0.64	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	12.37	5.54	0.65	1.95	0.65	0.00	0.00	0.65	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	26.58	10.04	2.07	0.30	2.66	1.18	0.59	0.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	21.07	3.27	1.00	1.42	1.28	0.28	0.43	0.28	0.14	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	6.67	0.33	0.33	0.16	0.33	0.00	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	6.70	2.44	0.61	1.52	0.91	0.00	0.61	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	4.04	1.52	0.25	0.51	0.25	0.00	0.00	0.00	0.00	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.20	3.34	0.48	0.48	0.48	0.00	0.00	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	19.17	5.90	1.33	0.88	0.88	0.44	0.15	0.29	0.29	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	10.12	8.18	1.08	0.86	0.43	0.43	0.00	0.00	0.43	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	12.18	5.67	0.63	1.05	1.05	0.00	0.42	0.21	0.10	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	6.96	1.70	0.31	0.62	0.62	0.31	0.31	0.00	0.15	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	1.08	0.00	0.00	1.08	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	10.46	3.29	0.00	0.90	0.00	0.00	0.30	0.00	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.07	2.39	0.00	0.34	0.00	0.00	0.00	0.00	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	8.01	4.00	0.00	0.63	0.47	0.24	0.31	0.24	0.31	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	52.64	4.33	1.01	1.81	3.12	1.51	0.20	0.10	0.81	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	13.20	7.51	2.96	1.14	0.23	0.23	0.23	0.23	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.62	1.81	0.00	0.60	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	15.63	10.33	0.53	1.06	1.06	1.06	0.00	0.26	0.53	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	8.92	5.73	0.67	1.20	0.27	0.27	0.00	0.13	0.13	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	10.89	6.26	0.75	1.25	0.63	0.25	0.13	0.25	0.13	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	1.78	0.51	0.00	0.25	0.25	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	13.57	5.13	0.60	0.75	1.66	0.15	0.00	0.30	0.15	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	1.50	3.00	0.00	0.75	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	2.58	15.51	3.88	0.00	0.00	0.00	0.00	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	12.56	5.58	0.93	0.93	1.86	0.93	0.00	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	5.05	1.51	0.00	0.50	0.50	0.50	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	11.28	0.94	0.31	0.00	0.00	0.63	0.63	0.31	0.00	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.36	0.59	0.00	0.29	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	13.75	4.83	0.83	1.25	0.58	0.42	0.25	0.17	0.42	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	10.28	3.27	0.00	0.47	0.00	0.00	0.00	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	15.11	1.01	0.29	0.14	0.43	0.43	0.29	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	12.49	3.06	0.25	0.25	0.51	0.76	0.00	0.25	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	4.89	0.94	0.19	0.19	0.19	0.38	0.19	0.00	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	12.58	5.17	1.54	0.70	1.26	0.00	0.28	0.14	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	19.94	2.68	0.67	0.84	1.01	0.17	0.17	0.25	0.08	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.24	0.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	12.72	0.98	0.49	0.49	0.49	0.49	0.00	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	17.01	2.65	0.22	1.33	0.66	0.44	0.22	0.22	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	5.27	2.05	0.00	0.29	0.29	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	6.03	3.50	0.58	1.17	0.97	0.19	0.00	0.19	0.00	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	19.57	1.85	0.79	0.53	0.26	1.06	0.00	0.00	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	12.65	3.72	0.37	0.00	0.37	0.00	0.00	0.00	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	55.70	6.47	2.87	1.80	1.80	1.80	0.00	0.00	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	28.39	2.27	1.14	0.85	1.14	0.28	0.00	0.28	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	19.30	3.94	1.18	0.79	0.79	0.39	0.00	0.00	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	11.94	2.79	1.02	1.27	0.25	0.00	0.25	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	13.58	2.40	0.40	0.80	0.40	0.00	0.00	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	8.36	3.76	0.42	0.00	0.84	0.00	0.00	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	7.33	2.29	0.46	0.92	0.92	0.00	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	10.27	2.86	0.17	0.34	0.84	0.00	0.34	0.00	0.17	0.17
Synoviocyte, donor2	11368-117I9	2.68	3.18	0.67	1.01	0.67	0.00	0.00	0.17	0.00	0.34
Synoviocyte, donor3	11440-118H9	2.90	2.23	1.12	1.34	0.45	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	8.22	2.86	0.00	0.71	1.07	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	3.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	6.25	3.70	1.62	0.00	0.93	0.23	0.46	0.00	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	26.45	1.22	0.07	0.14	0.36	1.22	0.07	0.00	1.22	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	15.08	0.77	0.77	0.00	0.00	0.39	0.00	0.00	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	20.04	1.15	0.57	0.00	0.57	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	27.56	10.33	1.48	2.83	2.21	0.74	0.37	0.37	0.49	0.62
Urethra, donor2	10319-105A4	7.19	5.40	0.00	3.60	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	16.74	0.80	0.27	0.00	0.00	1.06	0.53	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	10.41	0.80	0.00	0.00	0.40	0.00	0.00	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	14.90	1.38	0.00	0.23	0.69	0.46	0.00	0.00	0.23	0.23
Urothelial cells, donor0	11216-116B1	53.49	4.01	0.67	0.22	1.56	1.78	0.00	0.22	1.11	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	22.24	6.23	0.00	0.00	1.78	0.00	0.00	0.00	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	42.89	18.58	0.00	0.00	0.00	0.00	0.00	1.43	1.43	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	8.90	2.05	0.00	0.00	0.68	0.68	0.00	1.37	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	21.69	5.85	0.34	0.34	0.69	0.34	0.00	0.00	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	23.24	5.23	0.58	0.58	0.00	0.00	0.00	0.00	0.58	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	18.74	5.21	0.00	0.00	0.00	1.04	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	24.78	9.18	0.00	0.00	0.00	0.00	0.00	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	15.52	1.83	0.91	1.83	1.83	0.00	0.00	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	5.43	2.84	0.25	0.37	0.25	0.37	0.12	0.12	0.49	0.25
Wilms' tumor cell line:HFWT	10597-108E3	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	37.71	3.63	0.00	0.28	1.12	0.84	0.28	0.28	1.12	0.28
achilles tendon, donor2	10292-104G4	4.13	8.27	0.00	0.00	2.07	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	13.77	4.08	0.25	0.76	1.53	0.51	0.25	0.00	0.25	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	134.43	68.49	19.50	3.48	5.80	5.11	3.95	4.88	2.79	1.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	398.03	136.28	29.08	8.31	7.48	11.75	17.57	8.31	6.65	2.37
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	177.42	110.21	17.96	5.99	5.71	5.44	12.52	3.54	12.52	2.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	124.52	56.22	9.28	0.28	5.06	5.06	11.24	1.12	2.53	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	115.47	23.90	5.08	3.81	6.13	3.38	2.33	2.11	0.85	1.90
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	176.12	27.49	4.08	7.89	4.90	5.17	2.99	5.17	3.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	143.65	80.64	16.30	3.97	2.20	5.73	6.17	3.97	4.41	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	158.44	85.35	23.28	3.27	1.63	6.53	6.53	3.68	4.08	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	126.20	86.98	24.46	3.11	3.49	7.38	5.82	13.59	4.66	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	14.54	10.12	2.94	2.58	2.02	1.10	0.37	2.58	1.10	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	202.83	66.31	7.80	0.00	0.00	7.80	3.90	7.80	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	102.25	17.43	3.72	1.16	2.56	3.72	2.09	1.16	1.63	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	106.41	53.59	15.79	2.85	3.88	0.78	3.11	5.18	2.33	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	112.81	30.10	10.23	0.88	5.26	3.21	2.34	3.21	0.58	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	318.83	102.25	29.74	2.79	10.22	9.30	6.97	24.17	10.69	3.72
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	57.99	8.64	0.82	1.65	3.29	0.82	0.41	0.41	2.47	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	40.82	19.95	4.91	1.84	1.84	0.61	5.22	4.30	1.53	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	78.51	40.11	8.53	2.99	1.71	2.13	2.99	6.40	0.43	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	84.01	53.99	10.31	2.43	2.73	3.94	4.25	5.76	1.21	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	83.77	51.03	8.42	1.68	4.09	3.13	2.65	7.22	0.72	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	50.12	6.01	1.34	1.56	2.90	1.11	0.22	1.56	1.11	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	66.71	15.34	1.67	1.33	1.67	2.00	0.33	0.33	1.33	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	159.81	14.87	0.00	0.00	3.72	7.43	1.86	3.72	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	45.95	6.78	1.13	1.13	2.26	2.26	0.75	0.00	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	165.73	108.16	18.32	1.74	6.11	6.11	10.47	6.11	4.36	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	149.96	31.87	13.12	3.75	3.75	5.62	7.50	1.87	3.75	3.75
adenocarcinoma cell line:IM95m	10796-110I4	0.00	15.31	0.47	0.24	0.00	0.00	0.00	0.47	0.00	1.65
adipose tissue, adult, pool1	10010-101C1	10.55	4.81	0.78	1.24	2.02	0.16	0.16	0.62	0.00	0.31
adipose, donor1	10184-103D4	5.86	9.97	4.10	0.59	0.00	1.17	0.59	3.52	0.59	0.00
adipose, donor2	10185-103D5	5.27	2.84	2.43	0.41	0.00	0.00	1.22	0.81	0.41	0.41
adipose, donor3	10186-103D6	9.80	7.90	2.18	0.54	0.27	0.27	2.18	1.36	0.27	0.27
adipose, donor4	10187-103D7	4.33	4.33	0.00	1.73	0.87	0.00	0.87	0.00	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	15.47	16.73	0.32	0.79	2.37	0.32	0.32	0.00	0.95	1.10
adrenal gland, adult, pool1	10081-102A9	10.91	3.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	6.54	15.88	1.07	1.07	2.00	0.13	0.00	0.00	0.27	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	63.96	21.44	1.07	3.22	1.07	2.50	0.71	0.00	2.14	0.36
amniotic membrane cells, donor1	12235-129G3	104.10	5.10	1.16	0.46	2.78	2.55	0.23	0.23	1.39	0.00
amniotic membrane cells, donor2	12236-129G4	79.12	6.42	1.69	1.01	1.35	1.69	0.00	0.68	1.69	0.34
amniotic membrane cells, donor3	12237-129G5	111.95	7.07	0.59	0.29	4.42	2.36	0.00	0.00	4.42	0.88
amygdala - adult, donor10196	10167-103B5	4.74	10.67	1.19	1.19	0.00	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	4.06	10.54	0.81	2.03	0.61	0.20	0.00	0.41	0.00	0.20
amygdala, newborn, donor10223	10360-105E9	4.20	3.87	0.32	1.61	0.32	0.00	0.32	0.32	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	18.97	3.18	0.64	0.38	0.76	0.51	0.51	0.25	0.00	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	25.37	13.90	2.21	3.75	0.88	0.66	0.22	0.88	1.32	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	128.94	70.82	9.69	0.67	2.34	5.68	9.02	0.67	4.01	3.67
aorta, adult, pool1	10052-101G7	6.86	4.71	0.78	1.37	0.59	0.20	0.00	0.00	0.00	0.59
appendix, adult	10189-103D9	17.85	17.08	1.94	0.78	1.16	0.39	0.39	0.00	0.00	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	24.08	22.01	4.82	0.69	1.03	0.00	0.00	0.69	0.69	1.72
artery, adult	10190-103E1	2.72	1.36	0.00	1.36	0.00	0.00	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	13.04	14.92	1.59	1.45	1.16	0.29	0.43	0.87	1.01	1.01
b cell line:RPMI1788	10427-106D4	38.66	14.42	1.78	0.30	3.42	0.59	0.45	0.30	0.45	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	60.48	7.77	0.83	0.28	1.94	1.66	1.11	0.55	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	97.54	15.68	0.79	0.99	2.58	2.38	0.79	0.60	0.60	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	3.51	38.83	2.85	1.67	0.00	0.50	0.17	2.34	1.34	1.51
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	24.61	44.18	3.91	1.12	0.00	0.56	3.91	3.91	1.12	0.56
bladder, adult, pool1	10011-101C2	8.69	10.10	0.54	1.09	1.30	0.11	0.11	0.43	0.00	0.22
blood, adult, pool1	10053-101G8	4.43	2.21	0.00	0.00	2.21	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	15.41	3.43	0.86	4.28	0.00	0.00	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	10.80	8.10	1.35	0.67	1.35	0.67	0.67	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	4.10	9.23	0.00	1.03	1.03	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	2.45	12.47	0.89	1.00	0.67	0.00	0.11	0.11	0.00	0.45
brain, fetal, pool1	10085-102B4	0.00	5.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	0.00	3.96	0.00	0.33	0.00	0.00	0.00	0.00	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.00	1.37	0.25	0.00	0.00	0.00	0.00	0.25	0.00	0.00
breast, adult, donor1	10080-102A8	9.47	3.79	0.63	0.63	0.00	0.00	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	68.98	18.55	1.78	1.27	2.54	2.03	0.64	1.02	0.25	1.40
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	0.00	16.70	2.47	1.55	0.00	0.00	0.00	1.55	1.55	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	32.46	4.83	1.15	1.38	1.61	0.23	0.23	0.00	1.38	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	10.65	14.77	0.97	2.18	0.00	0.73	0.00	0.48	0.24	0.97
carcinoid cell line:NCI-H1770	10703-109H1	0.00	0.94	0.00	0.47	0.00	0.00	0.00	0.00	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	6.02	10.28	0.88	1.31	0.33	0.44	0.00	0.00	0.33	0.77
carcinoid cell line:SK-PN-DW	10719-109I8	0.95	2.54	0.32	0.63	0.32	0.32	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	1.60	0.80	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	1.15	23.03	1.15	2.30	0.00	0.00	0.00	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	5.35	17.23	2.01	2.68	0.84	0.00	0.67	0.00	0.17	1.34
caudate nucleus, adult, donor10258	10379-105H1	7.64	11.46	0.00	0.00	0.76	0.76	0.76	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	8.79	10.62	1.46	3.30	0.73	0.37	0.00	0.00	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	0.00	8.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	1.28	7.26	0.21	0.85	0.21	0.00	0.00	0.21	0.00	0.43
cerebellum, adult, pool1	10083-102B2	0.69	2.76	0.00	0.34	0.00	0.00	0.00	0.34	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	11.62	45.67	9.13	5.81	3.32	0.00	0.00	0.83	0.00	2.49
cerebral meninges, adult	10188-103D8	3.28	9.58	0.50	1.01	0.25	0.00	0.25	0.25	0.50	0.50
cerebrospinal fluid, donor2	10294-104G6	2.19	5.85	1.46	1.46	1.46	0.00	0.00	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	42.27	55.79	5.18	1.87	1.15	1.15	0.86	1.58	1.58	1.15
cervical cancer cell line:ME-180	10553-107I4	28.50	7.79	1.66	0.33	0.33	0.83	0.00	1.49	0.33	0.83
cervix, adult, pool1	10013-101C4	16.38	11.97	1.15	1.05	1.36	0.10	0.42	0.10	0.21	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	11.15	5.02	0.98	2.09	0.98	0.14	0.28	0.28	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	30.04	5.23	0.00	0.00	1.31	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	1.24	0.25	0.00	0.00	0.37	0.12	0.62	0.00	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	26.49	1.97	0.12	0.37	1.36	0.86	0.12	0.00	0.12	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	1.66	0.00	0.00	0.00	0.00	0.24	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	20.51	1.14	0.28	0.28	1.42	0.00	0.00	0.00	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	16.51	4.77	0.40	0.40	0.80	0.20	0.10	0.20	0.10	0.10
chorionic membrane cells, donor3	12240-129G8	10.99	1.10	1.10	0.55	0.55	0.00	0.00	1.10	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	51.50	14.14	4.04	12.12	0.00	3.03	1.01	3.03	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	71.65	36.31	10.18	1.54	4.23	2.50	10.18	2.69	1.54	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	119.74	5.28	2.11	0.63	3.59	4.22	2.11	0.63	1.48	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	81.66	2.31	0.26	0.51	5.91	2.82	1.28	0.00	0.77	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	74.50	2.42	0.00	0.24	4.35	1.45	1.94	0.00	0.97	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	79.61	1.22	0.20	0.41	3.26	1.83	1.43	0.00	0.20	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	111.60	2.06	0.29	0.29	3.53	4.42	2.36	0.00	3.53	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	203.03	25.28	4.43	1.04	4.43	6.78	6.52	1.04	1.04	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	16.92	9.83	0.46	0.00	1.14	0.23	0.46	0.23	0.46	1.60
clear cell carcinoma cell line:TEN	10636-108I6	6.94	11.97	1.56	0.69	0.17	0.00	0.17	0.52	0.00	0.35
colon carcinoma cell line:CACO-2	10513-107D9	65.90	18.49	2.38	1.65	2.38	2.38	0.55	1.28	1.65	0.37
colon carcinoma cell line:COLO-320	10420-106C6	77.54	11.40	0.76	0.38	3.04	2.66	0.38	0.38	0.76	1.14
colon, adult, donor1	10082-102B1	14.28	10.71	0.00	1.19	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	22.56	13.04	0.24	1.06	0.59	1.41	0.12	0.35	0.24	0.35
colon, fetal, donor1	10070-101I7	27.81	10.51	0.62	0.00	1.85	0.62	0.62	0.62	4.33	0.00
common myeloid progenitor CMP, donor1	12130-128D6	1613.40	591.27	68.75	27.50	41.25	64.17	50.42	96.25	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	150.22	75.11	0.00	0.00	0.00	0.00	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	152.55	48.44	9.35	2.55	10.20	4.67	36.97	1.70	6.37	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	71.39	16.00	3.17	1.06	3.47	1.66	9.81	0.60	1.51	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	71.35	20.16	4.37	1.13	5.50	2.68	9.87	0.14	1.41	0.14
corpus callosum, adult, pool1	10042-101F6	6.97	32.39	3.21	2.43	0.77	0.00	0.11	0.11	0.00	1.22
cruciate ligament, donor2	10295-104G7	4.86	2.43	0.81	0.81	1.62	0.00	0.81	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	7.22	8.83	1.61	0.80	0.80	0.80	0.00	0.00	0.80	0.00
diencephalon, adult	10193-103E4	2.40	11.76	1.20	1.20	0.24	0.24	0.00	0.00	0.24	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	15.38	4.36	1.38	0.92	1.61	1.15	0.00	0.00	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	45.13	5.13	0.26	0.26	1.03	1.54	0.26	0.26	0.51	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	4.09	7.94	0.96	0.24	0.00	0.00	0.00	0.24	0.00	0.00
ductus deferens, adult	10196-103E7	5.98	11.96	0.50	1.50	0.50	0.00	0.50	0.50	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	12.96	11.52	0.00	1.44	1.44	0.00	0.00	1.44	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	30.16	21.33	1.47	2.94	3.68	0.00	1.47	1.47	0.74	3.68
dura mater, adult, donor1	10041-101F5	11.56	5.20	0.99	3.22	1.24	0.41	0.00	2.23	0.00	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	30.42	5.55	1.33	2.22	1.11	3.55	1.78	0.89	0.89	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	17.48	6.59	0.86	0.72	0.57	0.72	0.29	0.43	0.29	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	12.33	4.93	0.00	0.00	0.62	0.00	0.62	0.00	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	22.40	5.45	0.30	0.00	0.30	0.61	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	25.63	4.63	0.00	0.00	0.93	1.85	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	13.13	2.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	25.81	10.73	0.67	0.34	3.02	2.01	0.67	0.34	1.01	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	0.00	11.24	0.00	2.72	0.18	0.00	0.00	0.18	0.91	1.45
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	1.13	0.16	0.00	0.16	0.00	0.16	0.00	0.00	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	44.91	5.22	1.00	0.22	0.67	1.22	0.11	0.22	0.67	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	100.42	19.47	1.98	0.55	2.20	2.31	0.66	1.43	1.10	0.44
epididymis, adult	10197-103E8	11.09	6.49	0.84	1.05	1.26	0.63	0.00	0.42	0.21	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	27.85	20.76	2.66	0.89	0.53	0.89	0.18	0.35	1.42	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	0.39	2.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	12.45	17.69	0.79	1.44	0.26	0.00	0.13	0.26	0.39	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	11.22	21.26	2.07	1.38	0.69	0.39	0.00	0.98	0.49	0.98
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	9.52	14.90	1.01	1.01	0.45	0.45	0.00	0.45	0.78	1.12
esophagus, adult, pool1	10015-101C6	14.97	8.92	0.42	0.85	1.59	0.11	0.11	0.21	0.11	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	21.67	29.43	6.26	1.50	1.50	0.75	0.13	3.13	0.25	0.88
eye - muscle inferior rectus, donor1	10272-104E2	7.24	2.41	2.41	4.83	0.00	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	4.21	4.21	0.00	2.10	0.00	0.00	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	10.42	7.44	1.49	2.98	1.49	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	8.03	5.73	2.29	0.00	1.15	0.00	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	7.29	1.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	10.42	4.32	0.25	0.25	1.02	0.51	0.00	0.25	0.00	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	32.06	4.49	0.77	0.51	1.03	0.51	0.64	0.38	0.51	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	27.54	7.36	0.71	0.24	1.90	1.66	0.24	0.24	1.19	0.24
frontal lobe, adult, pool1	10040-101F4	3.00	13.89	1.50	2.53	0.47	0.19	0.19	0.28	0.09	0.94
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	7.81	3.60	1.50	0.30	0.00	0.30	0.30	0.00	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	32.92	4.94	0.09	0.09	1.19	0.46	0.18	0.09	0.46	0.00
gall bladder, adult	10198-103E9	8.93	12.55	1.21	2.41	0.72	0.24	0.24	0.97	0.24	0.97
gamma delta positive T cells, donor1	11937-126A2	39.73	3.76	0.00	0.00	0.54	0.54	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	36.23	5.60	1.49	2.99	0.75	0.37	0.00	1.12	1.12	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	62.73	5.49	1.27	1.06	2.11	2.96	0.21	0.42	1.48	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	5.42	21.66	2.51	1.55	0.39	0.00	0.19	0.97	0.00	1.16
gastric cancer cell line:AZ521	10549-107H9	49.02	20.17	0.33	0.66	3.77	1.31	0.82	0.49	1.31	2.62
gastric cancer cell line:GSS	10560-108A2	37.52	10.98	0.00	0.92	1.83	4.58	0.00	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	36.95	5.16	0.00	0.11	1.49	1.26	0.46	0.11	0.46	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	16.38	2.80	0.56	0.14	0.56	0.28	0.14	0.14	0.14	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	2.74	3.74	0.25	0.75	0.00	0.00	0.00	0.25	0.25	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	86.66	22.69	3.06	2.64	2.74	2.85	1.16	0.63	1.37	1.16
glioblastoma cell line:A172, tech_rep2	10444-106F3	77.10	22.05	2.95	4.49	2.39	1.97	0.98	0.56	3.37	0.98
glioblastoma cell line:T98G	10485-107A8	29.36	25.28	2.76	5.41	0.88	0.88	0.22	1.88	1.88	1.66
glioma cell line:GI-1	10413-106B8	2.05	2.34	0.29	0.88	0.29	0.00	0.29	0.29	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	0.00	13.85	1.46	0.73	0.00	0.00	0.73	0.00	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	5.61	30.27	3.66	1.95	0.49	0.00	0.24	0.24	0.49	0.73
globus pallidus, adult, donor10258	10367-105F7	4.11	26.01	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	3.73	8.53	1.07	1.60	0.00	0.53	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	839.37	347.49	75.86	39.15	29.37	22.02	17.13	51.39	0.00	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	120.21	10.93	10.93	21.86	0.00	0.00	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	10.45	0.00	0.00	0.00	0.00	0.00	5.23	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	45.76	3.20	0.96	0.96	1.28	1.28	0.96	0.00	0.96	0.32
hIPS +CCl2, biol_rep1	14383-156B9	7.35	3.67	0.92	0.46	0.46	0.46	0.46	0.92	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	10.06	4.57	0.00	1.83	0.46	0.46	0.46	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	10.95	4.51	0.64	0.64	1.29	1.29	0.00	0.64	0.64	0.64
hIPS, biol_rep1	14380-156B6	7.19	1.44	2.87	4.31	1.44	1.44	0.00	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	9.60	7.54	0.69	2.74	0.00	2.06	0.69	0.00	0.00	0.69
hIPS, biol_rep3	14382-156B8	5.52	7.72	2.21	0.00	1.10	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	81.32	17.82	2.59	1.44	7.18	2.87	12.07	0.57	2.87	1.44
heart - mitral valve, adult	10205-103F7	7.47	11.66	0.60	2.69	1.20	0.60	0.00	0.30	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	10.98	9.41	2.88	2.09	1.31	0.26	0.26	0.26	0.52	0.52
heart - tricuspid valve, adult	10207-103F9	21.65	5.00	1.67	2.50	0.83	0.83	0.83	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	10.41	4.69	0.20	0.61	0.61	0.41	0.00	0.00	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	5.54	8.09	0.00	0.43	0.85	0.00	0.43	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	6.21	7.59	0.00	1.15	0.46	0.23	0.00	0.00	0.23	0.23
heart, fetal, pool1	10046-101G1	72.70	38.40	5.85	2.16	6.06	2.26	0.92	0.41	0.21	2.36
hepatic mesenchymal tumor cell line:LI90	10778-110G4	17.59	3.39	0.00	0.93	0.00	0.31	0.00	0.00	1.54	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	126.05	21.41	2.38	3.57	1.19	7.14	0.00	0.00	3.57	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	66.52	24.97	4.97	1.33	3.31	3.20	1.99	0.33	0.88	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	71.97	26.10	4.85	1.34	2.79	2.06	1.09	0.61	0.73	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	79.43	28.90	5.66	1.01	3.03	2.83	1.31	0.51	0.91	1.01
hepatoma cell line:Li-7	10484-107A7	0.00	3.89	0.00	0.78	0.00	0.00	0.00	0.00	0.11	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	12.96	17.19	2.61	0.80	1.21	0.40	0.00	0.70	0.40	0.80
hippocampus - adult, donor10196	10169-103B7	0.00	9.46	0.95	0.95	0.00	0.00	0.00	0.00	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	3.27	16.74	1.84	1.84	0.61	0.00	0.20	0.61	0.41	0.61
hippocampus, adult, donor10258	10374-105G5	1.99	4.98	1.00	1.49	0.00	0.00	0.50	0.50	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	2.11	4.23	1.06	1.41	0.70	0.00	0.35	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	3.66	3.05	0.00	0.00	0.61	0.61	0.00	0.00	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	3.93	5.89	0.39	0.39	0.59	0.00	0.39	0.20	0.39	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	4.06	4.32	0.00	1.02	0.51	0.00	0.51	0.00	0.51	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	2.26	2.82	0.00	0.00	0.00	0.00	0.00	0.56	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	3.10	2.32	0.00	0.00	0.26	0.26	0.00	0.26	0.26	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	5.31	3.42	0.76	0.00	0.76	0.00	0.00	0.38	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	7.01	4.96	1.46	0.29	0.00	0.00	0.58	0.58	0.00	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	6.25	6.25	0.86	0.43	1.72	0.43	0.43	0.86	0.86	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	8.34	7.09	2.09	0.00	1.25	0.83	0.00	2.09	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	20.84	9.00	1.66	1.42	2.37	0.95	2.13	1.89	0.47	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	18.32	10.13	1.45	0.80	1.45	1.61	1.61	0.64	0.16	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	23.57	11.45	1.35	0.67	2.02	1.35	0.00	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	2.03	4.38	0.63	0.47	0.00	0.00	0.00	0.00	0.16	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	0.98	5.90	0.00	0.98	0.00	0.49	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	3.49	3.49	1.75	0.00	0.00	0.00	0.87	0.00	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	6.49	4.01	1.91	0.76	1.34	0.38	0.19	1.72	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	7.41	5.23	1.74	0.44	0.44	0.87	0.44	0.44	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	10.00	7.50	1.50	0.50	0.50	0.00	0.00	0.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	6.03	8.10	1.32	0.38	1.32	0.00	0.38	0.75	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	10.46	9.09	1.36	0.00	1.36	0.45	0.00	0.91	1.36	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	6.89	5.64	1.25	0.31	0.63	0.00	0.00	1.57	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	19.11	8.33	2.12	0.49	1.63	0.49	0.98	1.31	0.33	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	18.00	11.61	3.77	0.58	1.45	0.87	2.03	2.03	2.03	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	23.32	13.45	3.89	0.90	1.20	0.60	0.30	1.20	1.49	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	5.54	7.94	0.37	0.55	0.00	0.37	0.37	0.18	0.37	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	6.28	5.99	0.57	0.00	1.14	0.00	0.57	0.00	0.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	5.31	6.94	0.41	1.22	0.00	0.00	0.00	0.00	0.00	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	7.39	6.34	1.06	0.35	0.00	0.35	1.41	1.41	1.06	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	6.02	4.75	0.63	0.32	0.00	0.00	0.32	1.27	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	12.71	4.84	2.12	1.21	1.51	0.00	0.30	0.30	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	15.00	5.69	3.10	0.00	0.52	2.07	0.00	2.07	0.52	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	12.62	11.29	2.66	0.66	2.66	0.00	0.66	0.00	0.66	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	13.85	10.00	3.08	0.77	0.77	0.00	0.26	1.28	1.03	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	23.78	10.99	3.32	1.79	1.53	0.26	1.28	1.02	1.28	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	21.20	11.36	1.51	0.76	1.51	0.76	0.00	1.51	1.51	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	26.21	10.42	2.35	0.67	2.35	1.34	1.01	2.02	0.67	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	3.62	6.76	0.48	0.72	0.24	0.24	0.48	0.00	0.00	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	7.13	9.36	0.00	0.89	0.45	0.00	0.45	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	6.34	6.83	0.49	0.00	0.00	0.00	0.00	0.00	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	7.64	4.28	1.83	0.61	0.31	0.31	0.31	0.92	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	19.52	13.01	3.25	0.00	0.00	0.00	0.00	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	7.94	6.95	0.66	0.66	0.33	0.00	0.00	2.32	0.33	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	7.11	3.28	0.55	0.55	0.00	0.55	0.00	1.64	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	9.77	5.07	1.45	0.36	0.36	1.09	0.36	0.36	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	5.34	6.41	0.00	0.36	1.07	0.00	0.36	0.71	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	14.32	8.35	1.19	0.00	1.19	0.00	0.00	1.19	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	20.86	15.44	3.11	0.81	1.76	0.54	1.35	2.57	0.68	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	14.28	8.35	1.62	0.27	0.54	0.54	1.08	1.08	0.54	0.27
immature langerhans cells, donor1	11904-125F5	16.71	11.38	1.45	5.81	0.73	0.24	0.48	3.63	0.24	0.97
immature langerhans cells, donor2	11905-125F6	27.72	5.54	0.79	5.54	1.58	0.79	0.00	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	3.79	14.67	1.14	2.74	1.04	0.00	0.00	0.38	0.19	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	21.13	1.63	0.00	0.65	0.33	1.95	0.00	0.00	0.65	0.00
kidney, adult, pool1	10017-101C8	9.81	7.81	0.70	1.50	0.10	0.00	0.10	0.40	0.10	0.80
kidney, fetal, pool1	10045-101F9	24.90	15.14	1.27	1.63	3.18	0.57	0.85	0.64	0.28	0.99
large cell lung carcinoma cell line:IA-LM	10509-107D5	125.40	4.12	0.57	0.57	8.66	6.53	1.56	0.43	1.85	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	2.07	12.44	0.69	0.41	0.00	0.14	0.00	0.14	0.14	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	14.13	1.65	0.18	0.00	0.18	0.73	0.00	0.00	0.18	0.00
left atrium, adult, donor1	10079-102A7	5.99	6.54	1.09	2.18	0.00	0.54	0.54	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	5.06	5.56	1.01	0.51	0.00	0.00	0.51	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	1.09	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	2.87	3.59	0.36	0.00	0.36	0.00	0.00	0.36	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	8.70	1.09	0.00	0.00	0.54	0.54	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	6.56	1.21	0.24	0.49	0.24	0.00	0.00	0.00	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	36.59	7.32	1.05	1.05	1.05	1.05	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	35.18	3.07	0.12	0.35	2.13	1.06	1.53	0.24	0.35	0.00
liposarcoma cell line:KMLS-1	10782-110G8	15.31	2.81	0.94	0.47	1.09	0.47	0.16	0.00	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	23.27	15.84	2.44	0.61	0.97	1.10	0.49	1.58	0.61	0.49
liver, adult, pool1	10018-101C9	10.70	3.89	0.00	0.32	0.65	0.00	0.16	0.00	0.00	0.32
liver, fetal, pool1	10086-102B5	4.70	3.76	0.00	0.94	0.94	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	1.02	16.77	1.02	1.02	0.15	0.00	0.00	0.15	0.15	0.15
locus coeruleus, adult, donor10252	10165-103B3	2.03	12.18	1.48	0.55	1.11	0.00	0.18	0.18	0.00	0.92
locus coeruleus, adult, donor10258	10375-105G6	1.41	4.23	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	2.94	4.21	0.84	1.68	0.42	0.42	0.00	0.42	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	0.97	11.07	0.28	0.55	0.00	0.00	0.00	0.42	0.14	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	17.92	1.38	0.00	1.38	0.00	1.38	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	20.56	5.67	0.00	0.40	0.26	1.05	0.26	0.26	0.00	0.26
lung, adult, pool1	10019-101D1	13.70	6.02	0.00	0.95	1.18	0.71	0.12	0.12	0.00	0.24
lung, fetal, donor1	10068-101I5	57.65	33.68	4.00	2.00	4.28	0.86	1.43	0.86	0.00	1.71
lung, right lower lobe, adult, donor1	10075-102A3	7.79	4.58	0.46	2.29	0.46	0.00	1.37	0.00	0.00	0.46
lymph node, adult, donor1	10077-102A5	7.57	0.47	0.00	0.47	0.95	1.42	0.00	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	34.19	8.55	1.53	0.66	2.41	1.32	0.00	0.22	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	875.37	168.43	45.28	30.49	43.32	43.62	9.21	15.09	11.02	8.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	67.96	9.34	3.40	1.70	0.85	0.85	0.00	1.70	0.85	0.00
mature adipocyte, donor1	12231-129F8	8.44	2.22	1.33	0.89	0.89	0.00	0.00	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	6.02	2.70	0.62	1.66	1.04	0.00	0.00	0.00	0.42	0.21
mature adipocyte, donor3	12233-129G1	7.59	2.13	0.95	0.47	0.71	0.24	0.00	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	7.90	1.58	0.00	0.00	0.79	0.00	0.00	0.00	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	35.98	20.01	2.38	2.14	3.81	1.43	0.48	0.00	0.48	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	0.00	5.64	3.38	0.00	0.00	0.00	0.00	0.00	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	2.02	16.74	0.74	2.57	0.00	0.00	0.18	0.00	0.55	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	1.27	4.45	0.32	0.64	0.00	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	4.69	4.69	0.43	1.71	0.43	0.00	0.43	0.85	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	1.01	11.48	0.84	0.68	0.00	0.00	0.17	0.00	0.00	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	3.18	14.22	1.91	3.61	0.64	0.00	0.21	0.21	0.00	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	3.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	1.79	5.38	0.72	0.72	0.72	0.00	0.00	0.00	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	2.60	7.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	3.72	12.07	1.39	0.77	0.62	0.00	0.00	0.00	0.31	0.00
medulla oblongata, adult, pool1	10038-101F2	6.20	19.59	1.47	1.71	0.65	0.00	0.08	0.33	0.16	0.65
medulla oblongata, newborn, donor10223	10361-105F1	3.47	4.86	0.35	1.04	1.04	0.00	0.00	0.00	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	55.13	17.27	1.99	0.44	1.33	4.21	1.11	1.33	0.66	0.00
medulloblastoma cell line:ONS-76	10759-110E3	44.51	20.91	4.04	1.10	1.59	1.35	0.98	0.98	0.61	0.86
melanoma cell line:COLO 679	10514-107E1	33.49	8.62	2.30	2.44	3.74	0.57	0.14	1.58	0.43	1.15
melanoma cell line:G-361	10465-106H6	26.33	4.07	0.54	2.17	2.71	0.27	0.00	0.81	0.27	0.27
meningioma cell line:HKBMM	10691-109F7	13.39	2.53	0.36	0.36	1.09	0.36	0.00	0.18	0.54	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	0.52	7.00	0.00	0.52	0.00	0.00	0.00	0.00	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	8.75	5.22	1.23	1.07	0.92	0.31	0.00	0.00	0.15	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	3.27	1.82	0.36	1.09	0.36	0.00	0.18	0.36	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	6.21	1.24	0.00	0.41	0.83	0.41	0.41	0.00	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	4.50	1.83	0.42	0.56	0.14	0.00	0.00	0.00	0.42	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	4.24	1.54	0.39	0.39	0.19	0.19	0.19	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	4.16	2.08	0.00	0.69	0.00	0.00	0.00	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	4.81	1.54	0.00	0.51	0.69	0.00	0.17	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	4.37	2.30	0.46	1.38	0.35	0.00	0.00	0.00	0.35	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	4.91	3.45	1.19	1.33	0.53	0.00	0.00	0.27	0.53	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	6.48	3.78	0.27	1.76	0.27	0.27	0.27	0.54	0.14	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	30.59	10.24	1.00	1.00	0.71	0.71	0.43	0.00	1.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	13.50	3.95	1.65	0.66	1.32	0.00	0.00	0.33	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	31.13	7.06	1.11	0.83	0.97	0.83	0.83	0.00	0.69	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	13.61	2.09	0.00	0.35	0.70	0.00	0.00	0.00	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	17.97	2.25	0.82	0.20	1.22	0.41	0.61	0.20	0.61	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	21.57	2.88	1.44	1.44	1.80	0.00	0.72	0.00	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	14.07	2.69	0.41	0.72	0.62	0.41	0.21	0.00	0.93	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	31.23	4.33	1.37	0.46	0.46	1.37	0.00	0.23	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	27.27	5.03	1.26	1.68	0.42	1.26	0.00	0.42	0.42	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	13.30	4.78	0.30	1.20	0.30	0.45	0.30	0.15	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	20.83	3.15	0.88	0.88	0.35	0.70	0.35	0.09	0.96	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	9.94	2.21	0.37	0.37	1.84	0.00	0.00	0.00	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	32.62	6.87	1.14	1.14	1.43	0.29	0.57	1.14	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	55.15	15.58	5.89	2.53	1.68	1.68	1.26	0.84	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	7.31	4.57	0.91	1.37	0.46	0.00	0.00	0.46	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	5.12	2.30	0.77	2.05	0.51	0.00	0.00	0.26	0.26	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	6.28	3.14	1.05	0.52	0.52	0.26	0.00	0.26	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	4.31	1.54	0.92	1.23	0.00	0.00	0.00	0.31	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	4.71	3.77	0.71	0.47	0.47	0.00	0.00	0.47	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	5.42	3.38	1.35	0.34	0.00	0.00	0.00	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	4.72	1.96	0.79	1.18	0.00	0.00	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	6.49	4.63	0.93	1.39	0.00	0.00	0.00	0.00	0.00	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	4.90	2.31	0.29	0.58	0.00	0.00	0.00	0.58	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	5.80	2.01	0.45	0.45	0.45	0.00	0.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	5.53	0.72	0.48	0.24	0.48	0.24	0.00	0.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	8.07	2.93	0.00	0.73	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	5.37	1.68	1.34	0.67	0.34	0.00	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	5.32	2.05	1.23	1.23	0.00	0.41	0.00	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	4.30	2.58	1.29	1.29	0.43	0.00	0.00	0.00	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	0.00	2.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	4.55	0.97	0.32	0.00	0.00	0.00	0.00	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	4.36	2.91	1.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	4.26	1.60	0.00	1.60	0.00	0.00	0.00	0.00	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.91	0.82	0.00	0.82	0.82	0.00	0.82	0.00	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	3.89	1.55	0.00	0.78	0.78	0.00	0.00	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	0.00	0.00	0.00	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	0.00	3.97	0.99	0.99	0.99	0.00	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	0.00	4.77	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	4.15	2.96	0.00	0.59	1.19	0.00	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	2.44	4.87	0.00	0.00	0.00	0.00	0.00	1.22	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	2.53	1.27	0.63	0.63	0.00	0.00	0.00	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	4.83	3.10	1.03	0.69	0.00	0.00	0.00	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2.04	1.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	2.38	2.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	2.95	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	2.18	0.31	0.31	0.31	0.00	0.00	0.00	0.00	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	4.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	1.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	4.82	2.07	0.69	0.69	0.69	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	3.96	1.98	0.99	0.49	0.49	0.49	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	4.49	2.24	0.00	1.12	1.12	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	3.18	0.00	0.64	0.00	0.64	0.64	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	1.61	2.01	0.40	0.00	0.40	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	1.82	1.82	1.82	0.00	0.00	0.00	0.00	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	4.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	2.47	1.65	0.82	0.82	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	4.56	2.18	0.60	0.60	0.60	0.00	0.40	0.40	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	3.57	0.97	1.30	0.97	0.00	0.00	0.32	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	6.11	3.06	1.02	1.02	0.00	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	81.24	22.44	3.87	4.64	3.87	1.55	2.32	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	32.60	7.32	0.24	0.24	3.54	0.71	0.47	0.47	0.71	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	62.09	7.18	1.85	4.63	1.85	0.93	1.16	0.46	2.78	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	51.28	21.37	4.27	8.55	4.27	4.27	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	35.14	9.14	2.57	1.23	0.41	1.34	0.21	0.72	0.62	0.21
mesothelioma cell line:Mero-25	10850-111F4	12.03	4.77	0.23	1.59	0.00	0.68	0.23	0.23	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	38.63	11.49	2.44	3.91	0.98	0.73	0.49	0.24	1.22	0.24
mesothelioma cell line:Mero-48a	10852-111F6	35.43	5.09	0.89	1.33	1.33	1.33	0.00	0.22	0.66	0.22
mesothelioma cell line:Mero-82	10853-111F7	10.51	5.26	1.84	2.10	0.79	0.26	0.00	0.26	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	73.88	26.55	3.74	2.04	0.68	2.55	0.68	0.51	1.19	0.17
mesothelioma cell line:Mero-84	10855-111F9	32.36	16.68	3.29	1.77	0.25	0.76	0.00	1.26	0.76	0.76
mesothelioma cell line:Mero-95	10856-111G1	28.78	8.90	0.41	1.66	0.62	1.45	0.41	0.62	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	21.37	3.15	0.66	0.66	0.33	0.17	0.00	0.17	0.33	0.33
mesothelioma cell line:NCI-H226	10846-111E9	64.25	12.31	2.53	1.45	1.81	2.17	0.54	2.17	1.45	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	22.89	15.03	1.88	3.25	0.34	0.51	0.17	0.85	0.51	0.17
mesothelioma cell line:NCI-H28	10845-111E8	31.04	29.52	7.63	4.07	1.78	0.51	0.00	1.02	0.76	1.27
mesothelioma cell line:No36	10857-111G2	19.25	5.55	1.96	0.00	0.33	0.98	0.00	0.98	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	13.01	5.15	0.54	0.54	0.00	0.54	0.00	0.27	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	14.97	8.44	0.38	1.73	0.38	0.96	0.00	0.19	0.00	0.77
migratory langerhans cells, donor2	11902-125F3	33.34	9.89	0.73	3.54	1.22	0.00	0.00	0.12	0.12	0.98
migratory langerhans cells, donor3	11903-125F4	27.10	5.74	0.54	1.26	2.15	0.54	0.18	0.54	0.00	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	14.69	4.24	0.33	0.33	0.33	0.33	0.33	0.33	0.98	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	6.15	3.39	0.64	0.64	0.21	0.00	0.42	0.00	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	27.41	16.13	1.15	1.15	0.23	1.38	0.69	0.46	0.69	1.61
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	54.23	15.60	3.43	2.85	2.85	1.71	7.42	0.19	0.57	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	30.31	10.35	3.70	1.48	2.40	0.55	0.55	1.48	0.74	0.18
myeloma cell line:PCM6	10474-106I6	31.23	32.62	6.13	4.94	0.79	1.19	0.00	0.99	2.57	1.78
myxofibrosarcoma cell line:MFH-ino	10600-108E6	10.15	3.55	0.51	2.03	0.51	0.00	0.00	0.00	1.01	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	7.45	6.08	1.37	2.94	0.59	0.20	0.00	0.20	0.00	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	23.29	3.01	0.00	0.00	0.56	0.45	0.11	0.00	0.22	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	23.24	2.43	0.15	0.07	0.15	0.51	0.07	0.07	0.15	0.29
nasal epithelial cells, donor2	12227-129F4	45.82	2.21	0.55	0.00	1.10	1.10	0.00	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	35.66	80.98	14.49	3.45	2.53	2.30	1.15	4.60	1.38	1.15
neuroblastoma cell line:NB-1	10539-107G8	85.50	108.70	23.39	2.99	4.86	4.68	5.43	2.25	3.37	1.87
neuroblastoma cell line:NBsusSR	10607-108F4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	96.90	76.22	13.23	2.98	5.59	8.01	3.35	0.93	2.05	2.98
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	0.00	0.00	0.64	0.64	0.00	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	18.10	4.26	1.60	0.80	1.86	0.27	0.53	0.27	0.00	0.00
neutrophil PMN, donor1	12133-128D9	14.87	44.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	33.82	13.02	2.03	0.17	2.88	1.01	1.52	0.17	0.34	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	5.60	26.42	1.60	4.00	0.00	2.40	0.00	0.00	0.00	2.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	10.90	3.53	1.28	0.96	0.96	0.00	0.32	0.64	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	2.89	10.25	1.05	3.42	0.26	0.00	0.00	1.31	1.84	0.53
nucleus accumbens, adult, pool1	10037-101F1	6.00	19.87	1.87	2.72	1.12	0.00	0.47	0.47	0.19	0.94
occipital cortex - adult, donor10196	10172-103C1	2.06	8.24	4.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	3.22	22.54	2.42	2.42	0.27	0.00	0.27	0.00	0.27	1.61
occipital cortex, newborn, donor10223	10355-105E4	3.28	3.28	0.36	2.18	0.00	0.00	0.00	0.36	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	1.57	17.06	0.79	1.05	0.52	0.00	0.00	0.52	1.05	0.00
occipital lobe, fetal, donor1	10073-102A1	1.72	5.15	0.43	0.43	0.43	0.00	0.00	0.43	0.00	0.00
occipital pole, adult, pool1	10036-101E9	2.05	7.57	0.63	1.34	0.87	0.00	0.00	0.08	0.00	0.47
olfactory region, adult	10195-103E6	2.10	12.99	1.72	0.96	0.76	0.00	0.00	0.00	0.19	0.57
optic nerve, donor1	10277-104E7	4.00	42.02	4.00	4.00	0.00	0.00	0.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	48.41	13.33	1.59	0.57	0.34	1.25	0.23	0.80	0.57	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	46.30	28.30	1.79	0.27	2.34	1.65	0.82	0.41	0.69	1.79
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	30.14	7.11	0.85	0.68	0.51	1.52	0.34	0.68	0.34	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	77.28	9.01	1.50	1.96	1.96	3.12	0.81	1.27	0.92	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	17.05	20.28	2.35	2.65	0.29	0.29	0.29	0.59	0.29	1.76
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	35.50	5.61	1.87	2.80	2.80	0.93	0.93	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	50.89	8.48	1.27	1.91	3.82	0.85	1.06	0.21	0.85	0.21
ovary, adult, pool1	10020-101D2	6.90	4.72	0.44	0.44	0.61	0.17	0.26	0.09	0.00	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	33.73	17.42	1.65	0.37	1.47	0.55	0.92	0.37	2.38	0.37
pancreas, adult, donor1	10049-101G4	21.63	2.82	0.94	0.94	0.00	0.94	0.94	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	1.96	0.00	0.00	0.00	0.28	0.28	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	38.16	12.95	2.38	1.53	0.34	1.70	0.51	0.85	0.51	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	141.74	18.38	1.49	0.99	2.15	4.64	1.82	2.15	0.66	0.17
paracentral gyrus, adult, pool1	10035-101E8	3.39	17.66	1.28	1.10	0.37	0.00	0.00	0.09	0.00	0.46
parietal cortex, adult, donor10258	10373-105G4	1.47	8.81	2.20	0.73	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	0.94	15.05	0.00	1.88	0.00	0.00	0.00	0.00	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	2.57	19.10	1.71	3.42	0.29	0.00	0.00	0.00	0.57	1.14
parietal lobe, adult, pool1	10034-101E7	2.47	15.86	2.20	1.94	0.97	0.00	0.00	0.35	0.00	0.62
parietal lobe, fetal, donor1	10072-101I9	2.91	13.58	3.88	0.00	0.97	0.00	0.97	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	5.23	4.11	0.37	2.62	1.12	0.37	0.00	0.00	0.37	0.00
parotid gland, adult	10199-103F1	5.55	1.85	0.62	0.00	0.00	0.00	0.00	0.00	0.62	0.00
penis, adult	10200-103F2	10.74	5.91	0.00	2.15	1.07	0.00	0.54	0.54	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	50.12	8.60	1.02	0.73	1.75	1.60	0.58	1.02	1.31	0.58
pineal gland - adult, donor10196	10179-103C8	12.26	46.44	7.74	1.94	3.23	0.00	0.00	0.65	0.00	2.58
pineal gland, adult, donor10252	10160-103A7	44.42	75.21	20.14	7.70	4.74	2.37	0.59	10.66	0.59	2.96
pineal gland, adult, donor10258	10377-105G8	13.17	31.98	6.27	3.14	1.25	0.63	0.63	3.14	0.63	1.25
pituitary gland - adult, donor10196	10180-103C9	5.06	5.06	0.00	4.05	0.00	0.00	0.00	0.00	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	6.25	15.64	2.61	4.69	0.00	0.52	0.00	0.00	0.52	2.08
pituitary gland, adult, donor10258	10378-105G9	4.26	6.81	1.70	0.00	0.00	0.00	0.00	0.00	0.00	1.70
placenta, adult, pool1	10021-101D3	39.99	8.71	1.40	1.61	1.83	0.65	0.11	0.54	0.43	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	33.64	12.05	0.93	1.46	2.25	1.06	0.66	0.40	0.40	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	8.72	8.40	1.25	2.65	0.16	0.16	0.00	0.00	0.16	0.93
pons, adult, pool1	10033-101E6	4.73	18.33	2.84	1.89	0.43	0.00	0.17	0.34	0.00	0.95
postcentral gyrus, adult, pool1	10032-101E5	1.92	13.08	1.05	2.27	0.96	0.00	0.00	0.44	0.00	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	752.90	181.95	25.10	35.55	31.37	14.64	4.18	75.29	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	88.13	11.02	5.51	5.51	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	23.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	1.46	2.04	0.00	0.29	0.00	0.00	0.00	0.00	0.00	0.15
prostate cancer cell line:PC-3	10439-106E7	16.52	6.53	0.00	0.36	0.36	0.54	0.00	0.18	0.54	0.36
prostate, adult, pool1	10022-101D4	11.16	8.25	0.91	1.18	0.63	0.00	0.09	0.27	0.00	0.45
putamen, adult, donor10196	10176-103C5	2.36	15.34	1.18	4.01	1.18	0.00	0.47	0.24	0.24	0.71
putamen, adult, donor10252	10152-102I8	3.92	35.29	1.96	1.96	0.00	0.00	0.00	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	2.19	3.28	1.09	3.28	1.09	0.00	0.00	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	6.04	11.11	2.66	1.21	0.00	0.00	0.00	0.48	0.00	1.45
putamen, newborn, donor10223	10365-105F5	3.00	11.99	2.25	0.75	0.00	0.00	0.75	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	16.58	5.53	1.75	1.16	0.29	0.87	0.87	1.75	0.00	0.00
rectum, fetal, donor1	10067-101I4	36.17	19.47	8.35	5.56	2.78	0.00	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	51.73	13.14	0.85	1.27	1.48	1.48	0.00	0.64	0.42	1.27
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	52.60	13.25	0.41	0.41	3.31	1.24	0.00	0.00	2.07	0.00
retina, adult, pool1	10030-101E3	9.74	7.26	1.19	1.39	1.49	0.00	0.10	0.00	0.00	0.10
retinoblastoma cell line:Y79	10475-106I7	2.86	7.27	0.26	0.26	0.26	0.00	0.00	0.52	0.26	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	36.52	10.45	0.49	0.98	1.60	1.97	0.37	0.00	0.61	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	292.45	66.08	17.15	1.69	14.62	8.44	7.87	5.34	12.94	2.53
sacrococcigeal teratoma cell line:HTST	10695-109G2	9.85	6.06	2.27	0.76	0.00	0.00	0.00	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	28.32	2.10	0.81	1.29	0.49	0.97	0.00	0.00	0.65	0.00
salivary acinar cells, donor2	11772-123I8	28.91	2.20	0.41	0.41	0.96	1.10	0.00	0.00	0.14	0.14
salivary acinar cells, donor3	11773-123I9	21.19	4.63	1.99	0.66	0.00	0.66	0.00	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	9.72	4.58	0.00	0.57	0.00	0.00	0.57	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	16.86	3.71	1.01	0.42	1.10	0.25	0.08	0.42	0.08	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	11.40	4.82	0.59	0.24	1.06	0.71	0.24	0.35	0.24	0.12
seminal vesicle, adult	10201-103F3	5.82	13.76	0.00	1.59	0.00	0.53	0.53	0.53	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	20.65	3.64	0.97	0.49	0.49	0.97	0.00	0.24	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	5.03	2.26	0.75	0.75	0.25	0.25	0.00	0.00	0.25	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	15.05	11.04	2.01	2.01	0.00	0.00	0.00	1.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	0.13	2.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	0.00	40.34	4.42	0.99	0.00	0.00	0.00	3.54	0.77	1.99
signet ring carcinoma cell line:NUGC-4	10483-107A6	53.55	42.58	3.23	1.94	0.52	1.55	0.00	0.90	2.32	1.81
skeletal muscle - soleus muscle, donor1	10282-104F3	4.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	5.28	1.68	0.00	0.24	0.24	0.00	0.00	0.12	0.12	0.00
skeletal muscle, fetal, donor1	10066-101I3	34.17	12.06	2.01	1.01	3.02	1.01	1.01	0.00	1.01	1.01
skin, adult, donor1	10074-102A2	33.93	0.00	0.00	0.00	0.00	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	42.92	10.10	2.52	1.26	3.16	1.89	1.26	0.63	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	1.33	4.00	0.33	1.33	0.00	0.00	0.00	0.33	0.00	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	23.64	25.85	4.73	7.88	2.21	1.58	0.32	0.63	0.95	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	0.00	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.19	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	39.72	13.68	0.82	2.64	2.47	3.63	0.16	0.00	0.99	1.48
small cell lung carcinoma cell line:NCI-H82	10842-111E5	29.44	21.23	0.80	0.32	1.93	0.97	0.16	0.00	0.48	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	0.87	9.81	0.65	3.05	0.00	0.00	0.00	0.00	0.00	0.44
small intestine, adult, pool1	10024-101D6	19.95	15.89	1.07	1.43	1.19	0.24	0.48	0.24	0.24	1.07
small intestine, fetal, donor1	10064-101I1	17.44	7.62	1.47	0.00	2.21	0.25	0.25	0.49	0.00	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	1.03	10.77	1.54	3.59	0.00	0.00	0.00	0.00	0.51	1.54
smooth muscle, adult, pool1	10048-101G3	7.50	14.22	1.29	2.84	1.03	0.00	0.26	0.78	0.00	1.55
somatostatinoma cell line:QGP-1	10781-110G7	5.36	20.91	1.07	2.14	0.00	0.00	0.27	0.00	0.27	1.34
spinal cord - adult, donor10196	10181-103D1	1.38	15.83	0.92	0.92	0.46	0.00	0.00	0.00	0.23	0.69
spinal cord, adult, donor10252	10159-103A6	5.13	10.65	1.18	0.79	1.18	0.00	0.00	0.00	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	0.69	6.92	0.69	0.69	0.69	0.00	0.00	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	5.49	14.64	1.83	1.22	0.00	0.00	0.00	0.61	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	10.56	9.64	1.38	1.38	0.00	0.00	0.00	0.00	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	18.37	4.18	1.05	1.34	0.30	1.05	0.15	0.00	0.15	0.00
spleen, adult, pool1	10025-101D7	13.00	4.85	0.33	1.43	0.66	0.55	0.00	0.11	0.00	0.44
spleen, fetal, pool1	10044-101F8	32.74	12.08	1.43	1.67	2.70	0.95	1.35	0.24	0.16	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	86.02	16.25	1.86	1.76	4.87	1.97	1.24	0.52	0.52	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	37.79	16.14	1.33	0.76	2.28	0.57	0.19	0.76	1.52	1.33
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	13.28	5.24	0.70	0.70	0.70	0.35	0.00	0.35	0.00	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	20.33	1.17	0.39	0.00	0.39	0.39	0.39	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	72.83	25.21	5.52	0.90	3.49	3.83	0.45	10.36	2.70	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	0.42	3.81	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	32.15	4.65	0.42	0.85	0.42	0.85	0.42	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	21.36	13.88	1.07	3.20	1.07	1.07	1.07	1.07	0.00	2.14
submaxillary gland, adult	10202-103F4	15.38	3.42	1.14	0.57	1.14	1.14	0.00	1.14	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	54.27	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	3.32	23.68	1.66	0.83	0.62	0.00	0.21	0.21	0.62	0.62
substantia nigra, adult, donor10258	10371-105G2	1.03	6.72	0.52	0.52	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	1.41	4.24	0.00	1.41	0.00	0.00	0.00	0.00	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	82.76	20.63	2.98	2.29	7.11	2.29	0.69	1.38	1.15	0.92
temporal lobe, adult, pool1	10031-101E4	2.54	11.53	0.85	2.12	0.85	0.08	0.17	0.17	0.00	0.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	2.85	8.55	3.56	1.42	0.71	0.00	1.42	0.00	1.42	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	3.96	7.47	0.88	1.32	0.00	0.00	0.44	0.00	0.00	0.44
tenocyte, donor1	11763-123H8	12.92	3.14	0.70	1.75	1.05	0.35	0.35	0.00	0.70	0.35
tenocyte, donor2	11765-123I1	6.87	3.05	0.76	0.76	0.00	0.00	0.00	0.38	0.00	0.38
tenocyte, donor3	11768-123I4	17.42	1.85	1.85	1.11	1.11	0.74	0.00	0.37	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	19.04	12.24	0.34	1.19	2.38	1.36	0.68	0.51	0.51	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	15.41	3.39	0.92	0.00	0.92	1.08	0.31	0.46	0.31	0.15
teratocarcinoma cell line:PA-1	10807-111A6	6.51	6.51	1.24	0.93	0.93	0.31	0.46	0.15	0.15	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	10.41	3.05	0.38	0.38	0.13	0.38	0.13	0.25	0.38	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	37.44	6.43	0.76	1.89	6.05	1.51	1.13	0.00	0.76	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	13.63	3.71	0.33	1.31	0.11	0.44	0.11	0.44	0.22	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	11.07	1.30	0.00	0.00	0.65	0.00	1.63	0.33	0.00	0.00
testis, adult, pool1	10026-101D8	6.01	4.29	0.54	0.54	1.29	0.21	0.75	0.43	0.00	0.43
testis, adult, pool2	10096-102C6	8.12	6.77	1.35	1.35	0.45	0.45	0.00	0.00	0.45	0.00
thalamus - adult, donor10196	10168-103B6	0.00	19.87	2.21	0.00	1.10	0.00	0.00	0.00	1.10	1.10
thalamus, adult, donor10252	10154-103A1	5.00	26.72	2.97	1.41	0.78	0.16	0.00	0.16	0.31	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	0.00	6.16	0.00	1.54	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	1.15	6.09	1.32	0.66	0.33	0.00	0.16	0.00	0.00	0.82
thalamus, newborn, donor10223	10366-105F6	0.00	2.88	0.00	0.00	0.00	0.00	0.00	0.00	0.58	0.00
throat, adult	10209-103G2	13.23	4.24	0.50	2.25	0.75	0.25	0.00	0.25	0.00	0.75
throat, fetal, donor1	10061-101H7	18.28	11.88	1.22	1.22	2.74	0.00	2.44	0.30	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	1.19	3.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.20
thymus, adult, pool1	10027-101D9	134.11	75.16	11.63	4.18	3.88	3.98	15.31	4.27	0.60	0.60
thymus, fetal, pool1	10043-101F7	97.77	57.25	8.42	1.66	5.40	2.29	8.00	1.87	0.52	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	32.31	3.06	0.93	0.40	0.27	1.20	0.13	0.13	0.40	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	30.03	3.77	0.84	0.14	1.26	0.42	0.56	0.28	0.56	0.00
thyroid, adult, pool1	10028-101E1	6.81	1.68	0.19	0.65	0.56	0.09	0.09	0.00	0.00	0.09
thyroid, fetal, donor1	10060-101H6	8.70	3.43	0.79	0.79	1.32	0.00	0.53	0.00	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	6.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	16.75	6.51	0.47	0.93	1.63	0.70	0.70	0.47	0.00	0.47
tongue, fetal, donor1	10059-101H5	16.55	6.70	1.58	1.18	1.18	0.00	0.79	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	25.85	11.42	1.00	1.70	1.40	0.70	0.20	0.30	0.00	0.80
trachea, adult, pool1	10029-101E2	13.74	5.48	0.57	1.06	1.06	0.33	0.00	0.33	0.00	0.41
trachea, fetal, donor1	10058-101H4	12.69	10.00	1.54	0.77	2.69	0.77	0.77	0.00	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	18.78	4.25	0.71	0.35	0.71	0.71	0.00	0.00	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	70.82	21.58	1.82	1.42	1.72	2.43	0.91	1.32	0.81	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	11.12	7.99	0.78	1.25	0.94	0.47	0.16	0.16	0.47	0.31
tridermal teratoma cell line:HGRT	10694-109G1	20.93	19.03	0.00	1.90	0.00	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	1.27	2.03	0.00	0.08	0.17	0.08	0.00	0.08	0.08	0.08
umbilical cord, fetal, donor1	10057-101H3	12.52	8.35	2.09	2.09	2.09	0.00	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	15.19	7.17	0.85	1.71	0.85	0.17	0.17	0.00	0.00	0.51
uterus, fetal, donor1	10055-101H1	17.41	23.04	2.05	2.05	3.58	0.00	0.51	0.51	2.56	0.00
vagina, adult	10204-103F6	7.11	6.46	0.00	1.29	1.29	0.00	0.00	0.00	0.00	0.65
vein, adult	10191-103E2	15.12	8.55	0.66	0.44	1.32	0.22	0.44	0.22	0.22	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	31.51	5.61	0.53	0.00	1.60	0.27	0.80	0.00	0.27	0.00